{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Text preprocessing"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "- Cleaning\n",
    "    - Non-text\n",
    "        - Punctuation\n",
    "        - JavaScript\n",
    "    - Encoding\n",
    "\n",
    "- Segmentation\n",
    "\n",
    "    - Sentence segmentation (sentence boundary recognition): Document -> Sentence\n",
    "\n",
    "    - Tokenization\n",
    "        - Character level\n",
    "        - Subword level: Byte Pair Encoding or WordPiece\n",
    "        - Word level\n",
    "\n",
    "- Normalization\n",
    "\n",
    "    - Spell checking and correction\n",
    "\n",
    "    - Lowercase\n",
    "    \n",
    "    - Standardization\n",
    "\n",
    "- Stopword removal\n",
    "\n",
    "- Morphological processing\n",
    "\n",
    "    - Stemming (词干提取): Remove derivation morphology: happiness -> happy\n",
    "    \n",
    "    - Lemmatization (词形还原): Remove inflection morphology: better -> good\n",
    "\n",
    "- build vocabulary from training set. \n",
    "\n",
    "    - all novel words at test set are replaced by [UNK] token.\n",
    "\n",
    "- Part-of-speech tagging\n",
    "\n",
    "- Entity recognition\n",
    "    - Special characters (emoticons and emojis)\n",
    "    - Named entity\n",
    "    - URLs, emails\n",
    "    - Numbers and dates\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### sentence segmentation"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sentence boundary recognition, also known as sentence segmentation, is the task of identifying the boundaries between sentences in a given text. \n",
    "\n",
    "It is an essential preprocessing step in many NLP tasks, such as parsing, machine translation, and information extraction. \n",
    "\n",
    "Sentence boundary recognition can be treated as a classification problem, where each potential boundary (usually a punctuation mark) is classified as either a sentence boundary or not.\n",
    "\n",
    "To perform sentence boundary recognition, various features can be used, including:\n",
    "\n",
    "- Punctuation: Periods `.`, question marks `?`, and exclamation marks `!`.\n",
    "\n",
    "- Formatting: Line breaks, paragraph breaks.\n",
    "\n",
    "- Fonts: Changes in font style or size.\n",
    "\n",
    "- Spacing: spaces before and after punctuation marks. For example, if there is no space after a period, it is less likely to be a sentence boundary.\n",
    "\n",
    "- Capitalization: The first word of a sentence is typically capitalized in many languages.\n",
    "\n",
    "- Case: Similar to capitalization, the case of characters in a word can provide clues about sentence boundaries.\n",
    "\n",
    "- Use of abbreviations: Certain abbreviations, like \"Dr.\" or \"a.m.\", may be followed by a period but not necessarily indicate the end of a sentence.\n",
    "\n",
    " "
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# subword tokenization"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## algorithm"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "| subword tokenization algorithm                | BPE                        | WordPiece                      |\n",
    "|------------------------|----------------------------|--------------------------------|\n",
    "| Vocab Initialization         | all raw characters   | all raw characters and some common subwords      |\n",
    "| Token selection        | Most frequent byte pairs | maximum likelihood of a token given its surrounding context.  |\n",
    "| Tokenization process   | Greedy longest match      | Greedy based on likelihood     |\n",
    "| Pros                   | Simple, language-agnostic | Better token selection in context |\n",
    "| Cons                   | Suboptimal token selection | language-dependent, Requires predefined vocabulary |\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## motivation"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "- unit of vocabulary in subword tokenization is subword (parts of words, bytes, characters)\n",
    "\n",
    "    byte: not refer to traditional definition of a storage unit -  byte = 8 bit. it means a string of characters the BPE algorithm operate on.\n",
    "\n",
    "- finite vocabulary assumption:  a fixed vocab of tens of thousands of words, built from the training set,  all novel words in test set are replaced as [UNK] token.\n",
    "\n",
    "- issue of finite vocab assumption: \n",
    "\n",
    "    - many languages has complex morphology, representing Tense, mood, definiteness, negation, information about the object, etc.\n",
    "    \n",
    "    - simply replace novel words of different morphology in test set as unknown tokens and have same embeddings will loss many information.\n",
    "\n",
    "    - morphology processing (stemming and lemmatization) can only address part of issue:\n",
    "    \n",
    "        - loss of information: words at base or root form result in ambiguity without context. morphological features carry important syntactic or semantic information are lost.\n",
    "\n",
    "        - languge-dependent: Stemming and lemmatization algorithms are typically language-dependent, requiring separate rule sets or resources for each language. This makes them less flexible and scalable than subword encoding techniques like BPE, which can be applied across languages.\n",
    "\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Tutorial"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## library"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import re\n",
    "import nltk\n",
    "from nltk.stem import WordNetLemmatizer \n",
    "import itertools\n",
    "from nltk import FreqDist\n",
    "from nltk.corpus import stopwords\n",
    "from nltk import ngrams\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "\n",
    "nltk.download('stopwords')\n",
    "stop_words = set(stopwords.words('english'))\n",
    "nltk.download('punkt') # download the punctuation file\n",
    "nltk.download('wordnet') # download Wordnet\n",
    "nltk.download('averaged_perceptron_tagger') # download POS tagger\n",
    "nltk.download('tagsets') # download the UPENN dataset\n",
    "nltk.download('maxent_ne_chunker') # download # named entity chunker\n",
    "nltk.download('words')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load text File\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Medical Information Mart for Intensive Care III (MIMIC-III) \n",
    "\n",
    "is a large, freely-available database comprising deidentified health-related data associated with over 40,000 patients who stayed in critical care units of the Beth Israel Deaconess Medical Center between 2001 and 2012.\n",
    "\n",
    "MIMIC-III is important dataset becuase:\n",
    "\n",
    "*   is freely available to researchers worldwide\n",
    "*   encompasses a diverse and very large population of ICU patients\n",
    "*   contains high temporal resolution data including lab results, electronic documentation, and bedside monitor trends and waveforms.\n",
    "\n",
    "The microbiology events file\n",
    "\n",
    "This file is comprised of around 2003 patients with 18 variables. \n",
    "\n",
    "Those variables describe the antibiotics that these patients took as a treatment for infections including medication id, name, dilution, and interaction with other drugs, the list of conditions they had. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(2003, 18)\n",
      "Index(['row_id', 'subject_id', 'hadm_id', 'chartdate', 'charttime',\n",
      "       'spec_itemid', 'spec_type_desc', 'org_itemid', 'org_name',\n",
      "       'isolate_num', 'ab_itemid', 'ab_name', 'dilution_text',\n",
      "       'dilution_comparison', 'dilution_value', 'interpretation',\n",
      "       'ab_interactions', 'ab_class'],\n",
      "      dtype='object')\n",
      "Size of data after dropping null columns is:  (915, 18)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>row_id</th>\n",
       "      <th>subject_id</th>\n",
       "      <th>hadm_id</th>\n",
       "      <th>chartdate</th>\n",
       "      <th>charttime</th>\n",
       "      <th>spec_itemid</th>\n",
       "      <th>spec_type_desc</th>\n",
       "      <th>org_itemid</th>\n",
       "      <th>org_name</th>\n",
       "      <th>isolate_num</th>\n",
       "      <th>ab_itemid</th>\n",
       "      <th>ab_name</th>\n",
       "      <th>dilution_text</th>\n",
       "      <th>dilution_comparison</th>\n",
       "      <th>dilution_value</th>\n",
       "      <th>interpretation</th>\n",
       "      <th>ab_interactions</th>\n",
       "      <th>ab_class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>134695</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90015.0</td>\n",
       "      <td>VANCOMYCIN</td>\n",
       "      <td>2</td>\n",
       "      <td>=</td>\n",
       "      <td>2.0</td>\n",
       "      <td>S</td>\n",
       "      <td>Leuprolide may decrease the excretion rate of ...</td>\n",
       "      <td>Diarrhea|Meningitis, Pneumococcal|Vancomycin|E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>134696</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90012.0</td>\n",
       "      <td>GENTAMICIN</td>\n",
       "      <td>&lt;=0.5</td>\n",
       "      <td>&lt;=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>S</td>\n",
       "      <td>Gentamicin may decrease the excretion rate of ...</td>\n",
       "      <td>Central Nervous System Infections|Decreased Pr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>134697</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90025.0</td>\n",
       "      <td>LEVOFLOXACIN</td>\n",
       "      <td>4</td>\n",
       "      <td>=</td>\n",
       "      <td>4.0</td>\n",
       "      <td>I</td>\n",
       "      <td>The risk or severity of QTc prolongation can b...</td>\n",
       "      <td>Decreased DNA Integrity|Salmonella Infections|...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>134698</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90016.0</td>\n",
       "      <td>OXACILLIN</td>\n",
       "      <td>=&gt;4</td>\n",
       "      <td>=&gt;</td>\n",
       "      <td>4.0</td>\n",
       "      <td>R</td>\n",
       "      <td>Leuprolide may decrease the excretion rate of ...</td>\n",
       "      <td>Gram-Positive Bacterial Infections|Enzyme Acti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>134699</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90011.0</td>\n",
       "      <td>TETRACYCLINE</td>\n",
       "      <td>&lt;=1</td>\n",
       "      <td>&lt;=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>S</td>\n",
       "      <td>Leuprolide may decrease the excretion rate of ...</td>\n",
       "      <td>Granuloma Inguinale|Cell Membrane Alteration|S...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>6</td>\n",
       "      <td>134700</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90006.0</td>\n",
       "      <td>ERYTHROMYCIN</td>\n",
       "      <td>=&gt;8</td>\n",
       "      <td>=&gt;</td>\n",
       "      <td>8.0</td>\n",
       "      <td>R</td>\n",
       "      <td>The risk or severity of bleeding can be increa...</td>\n",
       "      <td>Syphilis|Pimozide|Erythrasma|Gastroenteritis|S...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>7</td>\n",
       "      <td>134701</td>\n",
       "      <td>10006</td>\n",
       "      <td>142345</td>\n",
       "      <td>2164-10-23 00:00:00</td>\n",
       "      <td>2164-10-23 15:30:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80155.0</td>\n",
       "      <td>STAPHYLOCOCCUS, COAGULASE NEGATIVE</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90002.0</td>\n",
       "      <td>PENICILLIN</td>\n",
       "      <td>=&gt;0.5</td>\n",
       "      <td>=&gt;</td>\n",
       "      <td>1.0</td>\n",
       "      <td>R</td>\n",
       "      <td>The serum concentration of Moxifloxacin can be...</td>\n",
       "      <td>Bacterial Infections|Salmonella Infections|Ant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>38</td>\n",
       "      <td>134802</td>\n",
       "      <td>10019</td>\n",
       "      <td>177759</td>\n",
       "      <td>2163-05-14 00:00:00</td>\n",
       "      <td>2163-05-14 21:52:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80055.0</td>\n",
       "      <td>GRAM POSITIVE COCCUS(COCCI)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90006.0</td>\n",
       "      <td>ERYTHROMYCIN</td>\n",
       "      <td>=&gt;8</td>\n",
       "      <td>=&gt;</td>\n",
       "      <td>8.0</td>\n",
       "      <td>R</td>\n",
       "      <td>The risk or severity of bleeding can be increa...</td>\n",
       "      <td>Syphilis|Pimozide|Erythrasma|Gastroenteritis|S...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>39</td>\n",
       "      <td>134803</td>\n",
       "      <td>10019</td>\n",
       "      <td>177759</td>\n",
       "      <td>2163-05-14 00:00:00</td>\n",
       "      <td>2163-05-14 21:52:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80055.0</td>\n",
       "      <td>GRAM POSITIVE COCCUS(COCCI)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90002.0</td>\n",
       "      <td>PENICILLIN</td>\n",
       "      <td>&lt;=0.06</td>\n",
       "      <td>&lt;=</td>\n",
       "      <td>0.0</td>\n",
       "      <td>S</td>\n",
       "      <td>The serum concentration of Moxifloxacin can be...</td>\n",
       "      <td>Bacterial Infections|Salmonella Infections|Ant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>40</td>\n",
       "      <td>134804</td>\n",
       "      <td>10019</td>\n",
       "      <td>177759</td>\n",
       "      <td>2163-05-14 00:00:00</td>\n",
       "      <td>2163-05-14 21:52:00</td>\n",
       "      <td>70012</td>\n",
       "      <td>BLOOD CULTURE</td>\n",
       "      <td>80172.0</td>\n",
       "      <td>ENTEROCOCCUS FAECALIS</td>\n",
       "      <td>1.0</td>\n",
       "      <td>90025.0</td>\n",
       "      <td>LEVOFLOXACIN</td>\n",
       "      <td>1</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>S</td>\n",
       "      <td>The risk or severity of QTc prolongation can b...</td>\n",
       "      <td>Decreased DNA Integrity|Salmonella Infections|...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   index  row_id  subject_id  hadm_id            chartdate  \\\n",
       "0      1  134695       10006   142345  2164-10-23 00:00:00   \n",
       "1      2  134696       10006   142345  2164-10-23 00:00:00   \n",
       "2      3  134697       10006   142345  2164-10-23 00:00:00   \n",
       "3      4  134698       10006   142345  2164-10-23 00:00:00   \n",
       "4      5  134699       10006   142345  2164-10-23 00:00:00   \n",
       "5      6  134700       10006   142345  2164-10-23 00:00:00   \n",
       "6      7  134701       10006   142345  2164-10-23 00:00:00   \n",
       "7     38  134802       10019   177759  2163-05-14 00:00:00   \n",
       "8     39  134803       10019   177759  2163-05-14 00:00:00   \n",
       "9     40  134804       10019   177759  2163-05-14 00:00:00   \n",
       "\n",
       "             charttime  spec_itemid spec_type_desc  org_itemid  \\\n",
       "0  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "1  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "2  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "3  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "4  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "5  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "6  2164-10-23 15:30:00        70012  BLOOD CULTURE     80155.0   \n",
       "7  2163-05-14 21:52:00        70012  BLOOD CULTURE     80055.0   \n",
       "8  2163-05-14 21:52:00        70012  BLOOD CULTURE     80055.0   \n",
       "9  2163-05-14 21:52:00        70012  BLOOD CULTURE     80172.0   \n",
       "\n",
       "                             org_name  isolate_num  ab_itemid       ab_name  \\\n",
       "0  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90015.0    VANCOMYCIN   \n",
       "1  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90012.0    GENTAMICIN   \n",
       "2  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90025.0  LEVOFLOXACIN   \n",
       "3  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90016.0     OXACILLIN   \n",
       "4  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90011.0  TETRACYCLINE   \n",
       "5  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90006.0  ERYTHROMYCIN   \n",
       "6  STAPHYLOCOCCUS, COAGULASE NEGATIVE          1.0    90002.0    PENICILLIN   \n",
       "7         GRAM POSITIVE COCCUS(COCCI)          1.0    90006.0  ERYTHROMYCIN   \n",
       "8         GRAM POSITIVE COCCUS(COCCI)          1.0    90002.0    PENICILLIN   \n",
       "9               ENTEROCOCCUS FAECALIS          1.0    90025.0  LEVOFLOXACIN   \n",
       "\n",
       "  dilution_text dilution_comparison  dilution_value interpretation  \\\n",
       "0             2                   =             2.0              S   \n",
       "1         <=0.5                  <=             1.0              S   \n",
       "2             4                   =             4.0              I   \n",
       "3           =>4                  =>             4.0              R   \n",
       "4           <=1                  <=             1.0              S   \n",
       "5           =>8                  =>             8.0              R   \n",
       "6         =>0.5                  =>             1.0              R   \n",
       "7           =>8                  =>             8.0              R   \n",
       "8        <=0.06                  <=             0.0              S   \n",
       "9             1                   =             1.0              S   \n",
       "\n",
       "                                     ab_interactions  \\\n",
       "0  Leuprolide may decrease the excretion rate of ...   \n",
       "1  Gentamicin may decrease the excretion rate of ...   \n",
       "2  The risk or severity of QTc prolongation can b...   \n",
       "3  Leuprolide may decrease the excretion rate of ...   \n",
       "4  Leuprolide may decrease the excretion rate of ...   \n",
       "5  The risk or severity of bleeding can be increa...   \n",
       "6  The serum concentration of Moxifloxacin can be...   \n",
       "7  The risk or severity of bleeding can be increa...   \n",
       "8  The serum concentration of Moxifloxacin can be...   \n",
       "9  The risk or severity of QTc prolongation can b...   \n",
       "\n",
       "                                            ab_class  \n",
       "0  Diarrhea|Meningitis, Pneumococcal|Vancomycin|E...  \n",
       "1  Central Nervous System Infections|Decreased Pr...  \n",
       "2  Decreased DNA Integrity|Salmonella Infections|...  \n",
       "3  Gram-Positive Bacterial Infections|Enzyme Acti...  \n",
       "4  Granuloma Inguinale|Cell Membrane Alteration|S...  \n",
       "5  Syphilis|Pimozide|Erythrasma|Gastroenteritis|S...  \n",
       "6  Bacterial Infections|Salmonella Infections|Ant...  \n",
       "7  Syphilis|Pimozide|Erythrasma|Gastroenteritis|S...  \n",
       "8  Bacterial Infections|Salmonella Infections|Ant...  \n",
       "9  Decreased DNA Integrity|Salmonella Infections|...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Load the MICROBIOLOGYEVENTS MIMIC-III file \n",
    "data = pd.read_csv(\"/Users/wenxinxu/Desktop/CBB-750/data/MICROBIOLOGYEVENTS.csv\")\n",
    "\n",
    "# first check the size of the file\n",
    "print (data.shape)\n",
    "\n",
    "# Familiarize yourself with the features/variables\n",
    "print (data.columns)\n",
    "\n",
    "# last column has NaN values. drop ALL rows that have at least one column with NaN value.\n",
    "Edata = data.dropna()\n",
    "print (\"Size of data after dropping null columns is: \",Edata.shape)\n",
    "\n",
    "# reset index of rows. The rows from 8-37 were dropped becasue they had Nan Values. \n",
    "Edata.reset_index(inplace=True)\n",
    "# Print the first 10 rows in the data\n",
    "Edata.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Extract text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ciprofloxacin. Salmon Calcitonin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Gramicidin D. The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin. Desmopressin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Aldesleukin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin. The therapeutic efficacy of Insulin pork can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin pork can be increased when used in combination with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ciprofloxacin. Tositumomab may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cyclosporine may increase the nephrotoxic activities of Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ciprofloxacin. Cyanocobalamin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Ascorbic acid. The serum concentration of Ciprofloxacin can be increased when it is combined with Ascorbic acid. Folic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Folic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Icosapent may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Pyridoxine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Pyridoxine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ciprofloxacin. The metabolism of Fluvoxamine can be decreased when combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Valsartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Ramipril is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Flunisolide is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Flunisolide is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ciprofloxacin. Amphetamine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Amphetamine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Nicotine can be decreased when combined with Ciprofloxacin. The metabolism of Nicotine can be decreased when combined with Ciprofloxacin. Cevimeline may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Lorazepam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Esmolol is combined with Ciprofloxacin. The metabolism of Bortezomib can be decreased when combined with Ciprofloxacin. Carbidopa may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Carbidopa may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Phentermine can be decreased when combined with Ciprofloxacin. The metabolism of Phentermine can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Tramadol. The metabolism of Betaxolol can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Fluconazole. The therapeutic efficacy of Troglitazone can be increased when used in combination with Ciprofloxacin. Oseltamivir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Erythromycin. Hydroxocobalamin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Caffeine can be increased when it is combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Sildenafil. The metabolism of Dofetilide can be decreased when combined with Ciprofloxacin. The excretion of Ciprofloxacin can be decreased when combined with Pyrimethamine. The serum concentration of Ciprofloxacin can be increased when it is combined with Reserpine. The serum concentration of Ciprofloxacin can be increased when it is combined with Azithromycin. Ticlopidine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Pantoprazole. Torasemide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Citalopram. The metabolism of Eletriptan can be decreased when combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Nelfinavir. The therapeutic efficacy of Glimepiride can be increased when used in combination with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Indinavir. The metabolism of Ciprofloxacin can be decreased when combined with Indinavir. Gadodiamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Lovastatin can be decreased when combined with Ciprofloxacin. Cefotiam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ciprofloxacin. Temazepam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Methyclothiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. The serum concentration of Ciprofloxacin can be increased when it is combined with Reboxetine. Milrinone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Butabarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Nevirapine can be decreased when combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Ranolazine. Mesalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ziprasidone. The metabolism of Methysergide can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Cabergoline. The metabolism of Dapsone can be decreased when combined with Ciprofloxacin. The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin. Doxycycline may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Doxycycline may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Diethylstilbestrol. Calcium acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Anagrelide. The metabolism of Carmustine can be decreased when combined with Ciprofloxacin. The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Ciprofloxacin. Metoprolol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The therapeutic efficacy of Dicoumarol can be increased when used in combination with Ciprofloxacin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Ropinirole. The serum concentration of Ciprofloxacin can be increased when it is combined with Isradipine. Diatrizoate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Diatrizoate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Diatrizoate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Topiramate. Cefmetazole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Amsacrine. The serum concentration of Theophylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Theophylline can be increased when it is combined with Ciprofloxacin. The metabolism of Argatroban can be decreased when combined with Ciprofloxacin. The metabolism of Argatroban can be decreased when combined with Ciprofloxacin. Liothyronine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Disopyramide. The metabolism of Lidocaine can be decreased when combined with Ciprofloxacin. Pamidronic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Pamidronic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Clemastine. The therapeutic efficacy of Acarbose can be increased when used in combination with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Venlafaxine. The metabolism of Conjugated estrogens can be decreased when combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Ciprofloxacin. Bleomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Chlorambucil. Etomidate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Etonogestrel may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Morphine. The serum concentration of Ciprofloxacin can be increased when it is combined with Morphine. The metabolism of Ropivacaine can be decreased when combined with Ciprofloxacin. Tenofovir disoproxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Flucloxacillin. Ertapenem may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Mitomycin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ibutilide. Chlorthalidone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Pentobarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Valproic acid. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Valproic acid. Ciprofloxacin may decrease the excretion rate of Capreomycin which could result in a higher serum level. The metabolism of Zolmitriptan can be decreased when combined with Ciprofloxacin. The metabolism of Acetaminophen can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Gefitinib. Ciprofloxacin may decrease the excretion rate of Codeine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Codeine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Codeine which could result in a higher serum level. Piperacillin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Piperacillin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Ciprofloxacin can be decreased when combined with Dihydroergotamine. Ciprofloxacin may increase the QTc-prolonging activities of Amitriptyline. Floxuridine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tolcapone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Nitroprusside can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium glucoheptonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Hydromorphone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Indomethacin. Ethambutol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The therapeutic efficacy of Metformin can be increased when used in combination with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Methadone. The metabolism of Olanzapine can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Omeprazole. Pyrazinamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Terfenadine. The serum concentration of Ciprofloxacin can be increased when it is combined with Diltiazem. The serum concentration of Ciprofloxacin can be increased when it is combined with Protriptyline. The metabolism of Alfuzosin can be decreased when combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Clobazam. The serum concentration of Ciprofloxacin can be increased when it is combined with Megestrol acetate. The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ciprofloxacin. Aztreonam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Chlorzoxazone can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Mefloquine. The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Sapropterin. The serum concentration of Ciprofloxacin can be increased when it is combined with Vinorelbine. The serum concentration of Clozapine can be increased when it is combined with Ciprofloxacin. Sucralfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Grepafloxacin. The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ciprofloxacin. The metabolism of Levonorgestrel can be decreased when combined with Ciprofloxacin. Cidofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cidofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Mirtazapine can be decreased when combined with Ciprofloxacin. Thiethylperazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Timolol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Timolol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ciprofloxacin. Palonosetron may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Mexiletine can be decreased when combined with Ciprofloxacin. Dexrazoxane may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Amlodipine. The metabolism of Tacrine can be decreased when combined with Ciprofloxacin. The metabolism of Triamterene can be decreased when combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ciprofloxacin. Ciprofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Nimodipine. The risk or severity of tendinopathy can be increased when Beclomethasone dipropionate is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Progesterone. The metabolism of Sorafenib can be decreased when combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Nisoldipine. The metabolism of Eszopiclone can be decreased when combined with Ciprofloxacin. The metabolism of Alprazolam can be decreased when combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Loxapine. The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Ciprofloxacin. Pramipexole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The therapeutic efficacy of Acetohexamide can be increased when used in combination with Ciprofloxacin. Ampicillin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ampicillin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Phenoxymethylpenicillin. Secobarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Promazine can be decreased when combined with Ciprofloxacin. Spironolactone may increase the arrhythmogenic activities of Ciprofloxacin. Methylphenidate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ciprofloxacin. The metabolism of Zolpidem can be decreased when combined with Ciprofloxacin. The metabolism of Famciclovir can be decreased when combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ciprofloxacin. Trifluridine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ciprofloxacin. Nitric Oxide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Bendroflumethiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Allopurinol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftazidime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftazidime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Trimethoprim. Gemcitabine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Entecavir can be decreased when combined with Ciprofloxacin. The metabolism of Entecavir can be decreased when combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Betamethasone is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Teniposide. The risk or severity of QTc prolongation can be increased when Epirubicin is combined with Ciprofloxacin. Loracarbef may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Lansoprazole. The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ciprofloxacin. Ciprofloxacin can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy. Framycetin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Ciprofloxacin can be decreased when combined with Meperidine. The serum concentration of Ciprofloxacin can be increased when it is combined with Loratadine. Cefalotin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Prazosin. The metabolism of Imipramine can be decreased when combined with Ciprofloxacin. The metabolism of Nabumetone can be decreased when combined with Ciprofloxacin. Ketorolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Quinine. Tenoxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Fluoxetine. The metabolism of Duloxetine can be decreased when combined with Ciprofloxacin. The metabolism of Chlorpromazine can be decreased when combined with Ciprofloxacin. Amikacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Lenalidomide. The serum concentration of Ciprofloxacin can be increased when it is combined with Raloxifene. Celecoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The serum concentration of Ciprofloxacin can be increased when it is combined with Dicloxacillin. The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Sotalol. The metabolism of Ciprofloxacin can be decreased when combined with Buspirone. The therapeutic efficacy of Miglitol can be increased when used in combination with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ciprofloxacin. Cefotaxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ciprofloxacin. The metabolism of Darifenacin can be decreased when combined with Ciprofloxacin. The metabolism of Oxycodone can be decreased when combined with Ciprofloxacin. The therapeutic efficacy of Phenindione can be increased when used in combination with Ciprofloxacin. The metabolism of Flutamide can be decreased when combined with Ciprofloxacin. Tolmetin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cimetidine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The metabolism of Haloperidol can be decreased when combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Ritonavir. The serum concentration of Ciprofloxacin can be increased when it is combined with Triflupromazine. Ciprofloxacin may decrease the excretion rate of Vancomycin which could result in a higher serum level. The metabolism of Dextromethorphan can be decreased when combined with Ciprofloxacin. Ciprofloxacin may decrease the excretion rate of Cisplatin which could result in a higher serum level. The metabolism of Albendazole can be decreased when combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Caspofungin. The serum concentration of Ciprofloxacin can be increased when it is combined with Alitretinoin. Metolazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ciprofloxacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Ciprofloxacin. The serum concentration of Erlotinib can be increased when it is combined with Ciprofloxacin. The metabolism of Cyclophosphamide can be decreased when combined with Ciprofloxacin. The metabolism of Cyclophosphamide can be decreased when combined with Ciprofloxacin. The metabolism of Mephenytoin can be decreased when combined with Ciprofloxacin. The metabolism of Rofecoxib can be decreased when combined with Ciprofloxacin. Cefdinir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. The excretion of Guanidine can be decreased when combined with Ciprofloxacin. The serum concentration of Bendamustine can be increased when it is combined with Ciprofloxacin. The serum concentration of Pomalidomide can be increased when it is combined with Ciprofloxacin. The serum concentration of Ramelteon can be increased when it is combined with Ciprofloxacin. The serum concentration of Tasimelteon can be increased when it is combined with Ciprofloxacin. The metabolism of Brexpiprazole can be decreased when combined with Ciprofloxacin. The metabolism of Eliglustat can be decreased when combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Everolimus. The metabolism of Ciprofloxacin can be decreased when combined with Flibanserin. The metabolism of Ibrutinib can be decreased when combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Ivabradine. The metabolism of Ciprofloxacin can be decreased when combined with Ivacaftor. The metabolism of Lurasidone can be decreased when combined with Ciprofloxacin. The metabolism of Naloxegol can be decreased when combined with Ciprofloxacin. The metabolism of Olaparib can be decreased when combined with Ciprofloxacin. The metabolism of Sonidegib can be decreased when combined with Ciprofloxacin. The metabolism of Avanafil can be decreased when combined with Ciprofloxacin. The metabolism of Eplerenone can be decreased when combined with Ciprofloxacin. Didanosine can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Probenecid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Quinapril can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Sevelamer can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Iron Dextran can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Lanthanum carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric carboxymaltose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Iron sucrose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Iron sucrose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric pyrophosphate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Sodium ferric gluconate complex can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric cation can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric pyrophosphate citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium polycarbophil can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Cilostazol can be decreased when combined with Ciprofloxacin. The metabolism of Colchicine can be decreased when combined with Ciprofloxacin. The metabolism of Fentanyl can be decreased when combined with Ciprofloxacin. The metabolism of Iloperidone can be decreased when combined with Ciprofloxacin. The metabolism of Retapamulin can be decreased when combined with Ciprofloxacin. The metabolism of Tofacitinib can be decreased when combined with Ciprofloxacin. The metabolism of Vardenafil can be decreased when combined with Ciprofloxacin. The metabolism of Zopiclone can be decreased when combined with Ciprofloxacin. The serum concentration of Carbamazepine can be increased when it is combined with Ciprofloxacin. The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin. The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Ciprofloxacin. The serum concentration of Pirfenidone can be increased when it is combined with Ciprofloxacin. The serum concentration of Rasagiline can be increased when it is combined with Ciprofloxacin. The serum concentration of Roflumilast can be increased when it is combined with Ciprofloxacin. The serum concentration of Warfarin can be increased when it is combined with Ciprofloxacin. The serum concentration of Acenocoumarol can be increased when it is combined with Ciprofloxacin. The therapeutic efficacy of Ciprofloxacin can be decreased when used in combination with Nitrofurantoin. The therapeutic efficacy of Ciprofloxacin can be decreased when used in combination with Nitrofurantoin. The serum concentration of Tacrolimus can be increased when it is combined with Ciprofloxacin. The serum concentration of Tacrolimus can be increased when it is combined with Ciprofloxacin. The metabolism of Atorvastatin can be decreased when combined with Ciprofloxacin. The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Losartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Candesartan cilexetil is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Saralasin is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Candesartan is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Benazepril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Enalapril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Moexipril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Perindopril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Captopril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Cilazapril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Spirapril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Enalaprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Enalaprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Imidapril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Benazeprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Fosinoprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Ramiprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Trandolaprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Moexiprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Perindoprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Quinaprilat is combined with Ciprofloxacin. The risk or severity of hyperkalemia can be increased when Quinoline Yellow WS is combined with Ciprofloxacin. The therapeutic efficacy of Coumarin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Tioclomarol can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Fluindione can be increased when used in combination with Ciprofloxacin. Calcium glubionate anhydrous can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium lactate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium pangamate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium cation can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Phosphate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Triamcinolone. The risk or severity of tendinopathy can be increased when Cortivazol is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Halometasone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Cloprednol is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Fluclorolone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Loteprednol is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Prednisolone phosphate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Fluprednidene acetate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Methylprednisolone aceponate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Melengestrol acetate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Cortisone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Hydrocortisone aceponate. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Hydrocortisone acetate. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Hydrocortisone cypionate. The risk or severity of tendinopathy can be increased when Prednisone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Fluticasone propionate. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Hydrocortisone. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Prednisolone. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Methylprednisolone. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Aldosterone. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Fluticasone furoate. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Fluticasone. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Fluocinolone acetonide. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Budesonide. The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Tixocortol. The risk or severity of tendinopathy can be increased when Fludrocortisone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Mometasone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Trilostane is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Corticotropin is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Paramethasone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Ciclesonide is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Fluprednisolone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Meprednisone is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Melengestrol is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Clobetasol is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Prednylidene is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Mometasone furoate is combined with Ciprofloxacin. The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Ciprofloxacin. Magnesium sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium salicylate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Talc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium aspartate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium orotate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium lactate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Polaprezinc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc oxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc picolinate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ditiocarb Zinc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc Dibutyldithiocarbamate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Acetylcysteine zinc can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc ascorbate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc glycinate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Zinc chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Toremifene. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Imatinib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Thioridazine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Trovafloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Mifepristone. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Flupentixol. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Cocaine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Procainamide. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Arsenic trioxide. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Escitalopram. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Domperidone. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Sparfloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Halofantrine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Bepridil. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Paliperidone. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Lithium cation. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Temafloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Zuclopenthixol. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Tetrabenazine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Nilotinib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Vandetanib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Romidepsin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Asenapine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Artemether. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Lumefantrine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ribociclib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Glasdegib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Deutetrabenazine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Macimorelin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Terodiline. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Perflutren. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Atropine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Adenosine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Gadobenic acid. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Carbinoxamine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dolasetron. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Roxithromycin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Nalidixic acid. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Cinoxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Granisetron. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ondansetron. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Levosimendan. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Mesoridazine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Desloratadine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Telithromycin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dimenhydrinate. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Papaverine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Chlorpheniramine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Chlorpheniramine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Gemifloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ofloxacin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Acebutolol. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Oxprenolol. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Probucol. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Aceprometazine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Terlipressin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Prenylamine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Fluspirilene. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Telavancin. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Panobinostat. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Nilvadipine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Antazoline. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Bedaquiline. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Fendiline. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Butriptyline. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ceritinib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Lenvatinib. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Melperone. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dexchlorpheniramine maleate. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Amifampridine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Mizolastine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Oxatomide. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Sultopride. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Otilonium. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dexchlorpheniramine. The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Penfluridol. The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Moricizine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Azatadine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Risperidone is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Indapamide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Desflurane is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Encainide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Ziconotide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Fingolimod is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Flumequine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Talinolol is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Ciprofloxacin. The risk or severity of QTc prolongation can be increased when Inotersen is combined with Ciprofloxacin. The metabolism of Zafirlukast can be decreased when combined with Ciprofloxacin. The metabolism of St. John's Wort can be decreased when combined with Ciprofloxacin. The metabolism of St. John's Wort can be decreased when combined with Ciprofloxacin. The metabolism of Rufinamide can be decreased when combined with Ciprofloxacin. The metabolism of Lacosamide can be decreased when combined with Ciprofloxacin. The metabolism of Artesunate can be decreased when combined with Ciprofloxacin. The metabolism of Vitamin D can be decreased when combined with Ciprofloxacin. The metabolism of Dihydroergocornine can be decreased when combined with Ciprofloxacin. The metabolism of Dihydroergocristine can be decreased when combined with Ciprofloxacin. The metabolism of Dihydroergocryptine can be decreased when combined with Ciprofloxacin. The metabolism of Medical Cannabis can be decreased when combined with Ciprofloxacin. The metabolism of Cobimetinib can be decreased when combined with Ciprofloxacin. The serum concentration of Dyphylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Pentoxifylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Mercaptopurine can be increased when it is combined with Ciprofloxacin. The serum concentration of Mercaptopurine can be increased when it is combined with Ciprofloxacin. The serum concentration of Aminophylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Oxtriphylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Theobromine can be increased when it is combined with Ciprofloxacin. The serum concentration of Fenethylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Xanthine can be increased when it is combined with Ciprofloxacin. The serum concentration of Guanine can be increased when it is combined with Ciprofloxacin. The serum concentration of Propentofylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Uric acid can be increased when it is combined with Ciprofloxacin. The serum concentration of Cafedrine can be increased when it is combined with Ciprofloxacin. The serum concentration of Theodrenaline can be increased when it is combined with Ciprofloxacin. The serum concentration of Bamifylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Proxyphylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Pentifylline can be increased when it is combined with Ciprofloxacin. The serum concentration of Bromotheophylline can be increased when it is combined with Ciprofloxacin. The serum concentration of 8-chlorotheophylline can be increased when it is combined with Ciprofloxacin. The metabolism of Aripiprazole can be decreased when combined with Ciprofloxacin. The metabolism of Aripiprazole lauroxil can be decreased when combined with Ciprofloxacin. The metabolism of Hydrocodone can be decreased when combined with Ciprofloxacin. Piroxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Piroxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cephalexin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cephalexin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Fenoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Valaciclovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Valdecoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Sulindac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Bacitracin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Bacitracin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tobramycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Flurbiprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Adefovir dipivoxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Mannitol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Etodolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Mefenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Sulfasalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Gentamicin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Phenylbutazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Meloxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Carprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefaclor may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefaclor may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Diflunisal may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Etacrynic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Etacrynic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceforanide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Salicylic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Meclofenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Meclofenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Acetylsalicylic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Acetylsalicylic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Netilmicin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Carboplatin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Oxaprozin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Neomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ketoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Balsalazide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefditoren may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Streptomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Colistimethate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefuroxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefapirin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefadroxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefadroxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefprozil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefprozil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Kanamycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Kanamycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Olsalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefamandole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefazolin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefonicid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefotetan may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefoxitin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftizoxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefradine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Salsalate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Choline magnesium trisalicylate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefepime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftibuten may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefpodoxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Paromomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tiaprofenic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Oxyphenbutazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Niflumic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Latamoxef may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Nimesulide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Metamizole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftaroline fosamil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ceftaroline fosamil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Arbekacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Lornoxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Aceclofenac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Azapropazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Felbinac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Parecoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Salicylamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Kebuzone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Floctafenine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Fenbufen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Etofenamate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefaloridine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Benzydamine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Loxoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Dexketoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Droxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tolfenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Firocoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Clonixin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Morniflumate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Talniflumate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tenofovir alafenamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Robenacoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Dihydrostreptomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Flunixin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Hygromycin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Indobufen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Sisomicin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefatrizine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Dibekacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Micronomicin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Bumadizone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Alminoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Feprazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Lonazolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefodizime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefsulodin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefetamet may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Propyphenazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Proglumetacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ethenzamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Mofebutazone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Benorilate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Cefpirome may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Acemetacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Imidazole salicylate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Adefovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tenofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Tenofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Givosiran may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Varenicline which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Azelaic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pentostatin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methoxsalen which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Zanamivir which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fondaparinux which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Levocarnitine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gadoteridol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Labetalol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Bisoprolol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clofarabine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mecamylamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Metaxalone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Nilutamide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Phentolamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Furosemide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Oxacillin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Nedocromil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pralidoxime which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Meropenem which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Meropenem which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium chloride which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methimazole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tirofiban which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Phenelzine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Propantheline which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fenoldopam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ribavirin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fosfomycin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dobutamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Oxazepam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Temozolomide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Testolactone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tinidazole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Almotriptan which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Azacitidine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Rizatriptan which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pindolol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mepivacaine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Zaleplon which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dopamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Auranofin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Edrophonium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Edrophonium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Metyrapone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Guanfacine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Phylloquinone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Phylloquinone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Memantine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lubiprostone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Abacavir which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Amoxicillin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Amoxicillin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clonazepam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Flucytosine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Capecitabine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sibutramine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Rabeprazole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Rabeprazole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Doxacurium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Flavoxate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Bupropion which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Trimetrexate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Guanethidine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ifosfamide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Flumazenil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fomepizole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Estazolam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ketamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Epoprostenol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Iodixanol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Hydralazine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Penbutolol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tiotropium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Amrinone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Oxybenzone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Allylestrenol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fenproporex which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Metamfetamine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Valganciclovir which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sorbitol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pegaptanib which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pegaptanib which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Milnacipran which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clevidipine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clevidipine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Migalastat which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Brivaracetam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Icatibant which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Prasugrel which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Doripenem which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Nalmefene which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Droxidopa which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Flupirtine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dalfampridine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dimercaprol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mangafodipir which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Plerixafor which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pralatrexate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tiopronin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Deferiprone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Peginesatide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Aclidinium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Teduglutide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Formestane which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Trametinib which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Macitentan which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Gemeprost which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ceftolozane which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Vortioxetine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Idebenone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ancestim which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pentastarch which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dienogest which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chromic chloride which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ioversol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ioxilan which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Iopromide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Technetium Tc-99m disofenin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Viloxazine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Moxisylyte which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pholcodine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Piracetam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Nicorandil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methylene blue which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Methylene blue which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Toloxatone which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dextran which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Idarucizumab which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Choline C 11 which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sacubitril which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sulbactam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Mersalyl which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Invert sugar which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium acetate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium acetate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Octinoxate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Octinoxate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Ixazomib which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Selenious acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Opium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Selenium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chromium which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pyrantel which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Bicisate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tocopherol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Clove oil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pidotimod which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lesinurad which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Naldemedine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tropisetron which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Valbenazine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Benznidazole which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Vaborbactam which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Propiverine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Benserazide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Tiapride which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Inositol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Patent Blue which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Choline salicylate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pentetic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pentetic acid which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Cinnamaldehyde which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Cinnamyl alcohol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Solriamfetol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Pyrithione which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Resorcinol which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Golodirsen which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Emtricitabine which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Isotretinoin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Plazomicin which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lithium citrate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lithium succinate which could result in a higher serum level. Ciprofloxacin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level. Benzthiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Amiloride may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Cyclothiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Methazolamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Hydroflumethiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Acetazolamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Chlorothiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Trichlormethiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Diazoxide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Diclofenamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Polythiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Quinethazone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Piretanide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Azosemide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Canrenoic acid may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Canrenoic acid may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Potassium citrate may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Potassium citrate may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Isosorbide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Canrenone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Ibopamine may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Mefruside may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Cyclopenthiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Clopamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Xipamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Potassium may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. Drospirenone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Propylthiouracil. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Nizatidine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Niacin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Alendronic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Alendronic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Clofibrate. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Stavudine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Nafarelin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Mycophenolate mofetil. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Naltrexone. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Lamivudine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Penicillamine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Risedronic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Risedronic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Bumetanide. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Isoniazid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Methyldopa. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Methyldopa. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Cytarabine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ganciclovir. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Letrozole. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Minocycline. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Iloprost. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fluvastatin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Rosuvastatin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Procarbazine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Gemfibrozil. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Docetaxel. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Docetaxel. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Bezafibrate. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fusidic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fusidic acid. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Trabectedin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Raltegravir. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Pitavastatin. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Etofibrate. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Acipimox. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ciprofibrate. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ubidecarenone. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Mebeverine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ipecac. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Emetine. The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fenofibric acid. The metabolism of Ciprofloxacin can be decreased when combined with Tezacaftor. The metabolism of Ciprofloxacin can be decreased when combined with Lopinavir. The metabolism of Ciprofloxacin can be decreased when combined with Astemizole. The metabolism of Ciprofloxacin can be decreased when combined with Simvastatin. The metabolism of Ciprofloxacin can be decreased when combined with Ergotamine. The metabolism of Ciprofloxacin can be decreased when combined with Conivaptan. The metabolism of Ciprofloxacin can be decreased when combined with Tipranavir. The metabolism of Ciprofloxacin can be decreased when combined with Felodipine. The metabolism of Ciprofloxacin can be decreased when combined with Amiodarone. The metabolism of Ciprofloxacin can be decreased when combined with Bromocriptine. The metabolism of Ciprofloxacin can be decreased when combined with Saquinavir. The metabolism of Ciprofloxacin can be decreased when combined with Clomipramine. The metabolism of Ciprofloxacin can be decreased when combined with Dasatinib. The metabolism of Ciprofloxacin can be decreased when combined with Dasatinib. The metabolism of Ciprofloxacin can be decreased when combined with Darunavir. The metabolism of Ciprofloxacin can be decreased when combined with Dronedarone. The metabolism of Ciprofloxacin can be decreased when combined with Tolvaptan. The metabolism of Ciprofloxacin can be decreased when combined with Ticagrelor. The metabolism of Ciprofloxacin can be decreased when combined with Lomitapide. The metabolism of Ciprofloxacin can be decreased when combined with Rilpivirine. The metabolism of Cyclobenzaprine can be decreased when combined with Ciprofloxacin. The metabolism of Doxepin can be decreased when combined with Ciprofloxacin. The metabolism of Cisapride can be decreased when combined with Ciprofloxacin. The metabolism of Aprepitant can be decreased when combined with Ciprofloxacin. The metabolism of Triazolam can be decreased when combined with Ciprofloxacin. The metabolism of Levacetylmethadol can be decreased when combined with Ciprofloxacin. The metabolism of Tadalafil can be decreased when combined with Ciprofloxacin. The metabolism of Rivaroxaban can be decreased when combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Ethosuximide. The metabolism of Ciprofloxacin can be decreased when combined with Digitoxin. The metabolism of Ciprofloxacin can be decreased when combined with Ebastine. The metabolism of Fosaprepitant can be decreased when combined with Ciprofloxacin. The metabolism of Busulfan can be decreased when combined with Ciprofloxacin. The metabolism of Clindamycin can be decreased when combined with Ciprofloxacin. The metabolism of Maraviroc can be decreased when combined with Ciprofloxacin. The metabolism of Tianeptine can be decreased when combined with Ciprofloxacin. The metabolism of Esketamine can be decreased when combined with Ciprofloxacin. The metabolism of Nortriptyline can be decreased when combined with Ciprofloxacin. The metabolism of Clonidine can be decreased when combined with Ciprofloxacin. The metabolism of Alfentanil can be decreased when combined with Ciprofloxacin. The metabolism of Sirolimus can be decreased when combined with Ciprofloxacin. The metabolism of Pimozide can be decreased when combined with Ciprofloxacin. The metabolism of Paclitaxel can be decreased when combined with Ciprofloxacin. The metabolism of Temsirolimus can be decreased when combined with Ciprofloxacin. The metabolism of Quinidine can be decreased when combined with Ciprofloxacin. The metabolism of Efavirenz can be decreased when combined with Ciprofloxacin. The metabolism of Flecainide can be decreased when combined with Ciprofloxacin. The metabolism of Ciprofloxacin can be decreased when combined with Metoclopramide. The metabolism of Ciprofloxacin can be decreased when combined with Tamoxifen. The metabolism of Ciprofloxacin can be decreased when combined with Azelastine. The metabolism of Fluorouracil can be decreased when combined with Ciprofloxacin. The metabolism of Cinnarizine can be decreased when combined with Ciprofloxacin. The metabolism of Propranolol can be decreased when combined with Ciprofloxacin. The metabolism of Diclofenac can be decreased when combined with Ciprofloxacin. The metabolism of Guanabenz can be decreased when combined with Ciprofloxacin. The metabolism of Pemetrexed can be decreased when combined with Ciprofloxacin. The metabolism of Verapamil can be decreased when combined with Ciprofloxacin. The metabolism of Paroxetine can be decreased when combined with Ciprofloxacin. The metabolism of Thiabendazole can be decreased when combined with Ciprofloxacin. The metabolism of Riluzole can be decreased when combined with Ciprofloxacin. The metabolism of Zileuton can be decreased when combined with Ciprofloxacin. The metabolism of Clopidogrel can be decreased when combined with Ciprofloxacin. The metabolism of Etoposide can be decreased when combined with Ciprofloxacin. The metabolism of Estradiol can be decreased when combined with Ciprofloxacin. The metabolism of Acyclovir can be decreased when combined with Ciprofloxacin. The metabolism of Naproxen can be decreased when combined with Ciprofloxacin. The metabolism of Trifluoperazine can be decreased when combined with Ciprofloxacin. The metabolism of Perphenazine can be decreased when combined with Ciprofloxacin. The metabolism of Dacarbazine can be decreased when combined with Ciprofloxacin. The metabolism of Terbinafine can be decreased when combined with Ciprofloxacin. The metabolism of Ranitidine can be decreased when combined with Ciprofloxacin. The metabolism of Ethanol can be decreased when combined with Ciprofloxacin. The metabolism of Maprotiline can be decreased when combined with Ciprofloxacin. The metabolism of Alosetron can be decreased when combined with Ciprofloxacin. The metabolism of Lomefloxacin can be decreased when combined with Ciprofloxacin. The metabolism of Azathioprine can be decreased when combined with Ciprofloxacin. The metabolism of Frovatriptan can be decreased when combined with Ciprofloxacin. The metabolism of Levobupivacaine can be decreased when combined with Ciprofloxacin. The metabolism of Levobupivacaine can be decreased when combined with Ciprofloxacin. The metabolism of Cinacalcet can be decreased when combined with Ciprofloxacin. The metabolism of Selegiline can be decreased when combined with Ciprofloxacin. The metabolism of Tocainide can be decreased when combined with Ciprofloxacin. The metabolism of Praziquantel can be decreased when combined with Ciprofloxacin. The metabolism of Melatonin can be decreased when combined with Ciprofloxacin. The metabolism of Primaquine can be decreased when combined with Ciprofloxacin. The metabolism of Hesperetin can be decreased when combined with Ciprofloxacin. The metabolism of Leflunomide can be decreased when combined with Ciprofloxacin. The metabolism of Nifedipine can be decreased when combined with Ciprofloxacin. The metabolism of Carvedilol can be decreased when combined with Ciprofloxacin. The metabolism of Desipramine can be decreased when combined with Ciprofloxacin. The metabolism of Propafenone can be decreased when combined with Ciprofloxacin. The metabolism of Dexfenfluramine can be decreased when combined with Ciprofloxacin. The metabolism of Aminophenazone can be decreased when combined with Ciprofloxacin. The metabolism of Antipyrine can be decreased when combined with Ciprofloxacin. The metabolism of Bromazepam can be decreased when combined with Ciprofloxacin. The metabolism of Thiothixene can be decreased when combined with Ciprofloxacin. The metabolism of Etoricoxib can be decreased when combined with Ciprofloxacin. The metabolism of Genistein can be decreased when combined with Ciprofloxacin. The metabolism of Resveratrol can be decreased when combined with Ciprofloxacin. The metabolism of Phenacetin can be decreased when combined with Ciprofloxacin. The metabolism of Flunarizine can be decreased when combined with Ciprofloxacin. The metabolism of Lorcaserin can be decreased when combined with Ciprofloxacin. The metabolism of Lofexidine can be decreased when combined with Ciprofloxacin. The metabolism of Apremilast can be decreased when combined with Ciprofloxacin. The metabolism of Mianserin can be decreased when combined with Ciprofloxacin. The metabolism of Eltrombopag can be decreased when combined with Ciprofloxacin. The metabolism of Dapagliflozin can be decreased when combined with Ciprofloxacin. The metabolism of Pazopanib can be decreased when combined with Ciprofloxacin. The metabolism of Axitinib can be decreased when combined with Ciprofloxacin. The metabolism of Benzyl alcohol can be decreased when combined with Ciprofloxacin. The metabolism of Capsaicin can be decreased when combined with Ciprofloxacin. The metabolism of Perampanel can be decreased when combined with Ciprofloxacin. The metabolism of Stiripentol can be decreased when combined with Ciprofloxacin. The metabolism of Zotepine can be decreased when combined with Ciprofloxacin. The metabolism of Tegafur can be decreased when combined with Ciprofloxacin. The metabolism of Binimetinib can be decreased when combined with Ciprofloxacin. The metabolism of Voxilaprevir can be decreased when combined with Ciprofloxacin. The metabolism of Triclabendazole can be decreased when combined with Ciprofloxacin. The metabolism of Rucaparib can be decreased when combined with Ciprofloxacin. The metabolism of Dihydralazine can be decreased when combined with Ciprofloxacin. The metabolism of Enasidenib can be decreased when combined with Ciprofloxacin. The metabolism of Estradiol acetate can be decreased when combined with Ciprofloxacin. The metabolism of Estradiol benzoate can be decreased when combined with Ciprofloxacin. The metabolism of Estradiol cypionate can be decreased when combined with Ciprofloxacin. The metabolism of Estradiol valerate can be decreased when combined with Ciprofloxacin. The metabolism of Istradefylline can be decreased when combined with Ciprofloxacin. The excretion of Topotecan can be decreased when combined with Ciprofloxacin. The excretion of Abemaciclib can be decreased when combined with Ciprofloxacin. The excretion of Tipiracil can be decreased when combined with Ciprofloxacin. The excretion of Relebactam can be decreased when combined with Ciprofloxacin. The excretion of Relebactam can be decreased when combined with Ciprofloxacin. The excretion of Baricitinib can be decreased when combined with Ciprofloxacin. The excretion of Ciprofloxacin can be decreased when combined with Tafenoquine. The excretion of Ciprofloxacin can be decreased when combined with Rifamycin. The excretion of Ciprofloxacin can be decreased when combined with Bictegravir. The excretion of Ciprofloxacin can be decreased when combined with Brigatinib. The excretion of Ciprofloxacin can be decreased when combined with Pexidartinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Carbenicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Nafcillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Hetacillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Benzylpenicilloyl polylysine. The serum concentration of Ciprofloxacin can be increased when it is combined with Mezlocillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Cyclacillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Benzylpenicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Azlocillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Cloxacillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Amdinocillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Bacampicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Meticillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Pivampicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Pivmecillinam. The serum concentration of Ciprofloxacin can be increased when it is combined with Ticarcillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Azidocillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Temocillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Pheneticillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Propicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Sulbenicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Talampicillin. The serum concentration of Ciprofloxacin can be increased when it is combined with Metampicillin. Patiromer can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Aluminium can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium oxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Sodium bicarbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Aluminum hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Aluminum hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magaldrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium trisilicate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Bismuth subnitrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium silicate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Hydrotalcite can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Magnesium peroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Almasilate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Aloglutamol can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium silicate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Aluminium phosphate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Prucalopride can be decreased when combined with Ciprofloxacin. The therapeutic efficacy of Lactulose can be decreased when used in combination with Ciprofloxacin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Siponimod. The risk or severity of hypotension can be increased when Ciprofloxacin is combined with Tizanidine. The serum concentration of Ciprofloxacin can be increased when it is combined with Deflazacort. The risk or severity of QTc prolongation can be increased when Trazodone is combined with Ciprofloxacin. The bioavailability of Ciprofloxacin can be increased when combined with Phenazopyridine. The serum concentration of Pretomanid can be increased when it is combined with Ciprofloxacin. The metabolism of Entrectinib can be decreased when combined with Ciprofloxacin. Pitolisant may increase the QTc-prolonging activities of Ciprofloxacin. Lefamulin may increase the QTc-prolonging activities of Ciprofloxacin. The therapeutic efficacy of Glyburide can be increased when used in combination with Ciprofloxacin. The metabolism of Zanubrutinib can be decreased when combined with Ciprofloxacin. The serum concentration of Voxelotor can be increased when it is combined with Ciprofloxacin. The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Nateglinide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Pentamidine can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Tolazamide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Repaglinide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Phenformin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Glipizide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Gliclazide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Tolbutamide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Pioglitazone can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Gliquidone can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Sitagliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Sunitinib can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Exenatide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Mecasermin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Pramlintide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin aspart can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin aspart can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Glymidine can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Vildagliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Alogliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Saxagliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Saxagliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Liraglutide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Linagliptin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Glibornuride can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Benfluorex can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Empagliflozin can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Albiglutide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Dulaglutide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Lixisenatide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin degludec can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Bempedoic acid can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Carbutamide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Guar gum can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Semaglutide can be increased when used in combination with Ciprofloxacin. The therapeutic efficacy of Insulin detemir can be increased when used in combination with Ciprofloxacin. The serum concentration of Lemborexant can be increased when it is combined with Ciprofloxacin. The serum concentration of Lumateperone can be increased when it is combined with Ciprofloxacin. Iron can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Iron can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferumoxytol can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Prussian blue can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Prussian blue can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric ammonium citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferumoxsil can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferumoxides can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous bisglycinate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Gleptoferron can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric oxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous sulfate anhydrous can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferric hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous succinate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ferrous fumarate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Sodium feredetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Midazolam can be increased when it is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Vincristine. The serum concentration of Ciprofloxacin can be increased when it is combined with Amoxapine. The serum concentration of Ciprofloxacin can be increased when it is combined with Vinblastine. The serum concentration of Ciprofloxacin can be increased when it is combined with Doxazosin. The serum concentration of Ciprofloxacin can be increased when it is combined with Ivermectin. The serum concentration of Ciprofloxacin can be increased when it is combined with Chloroquine. The serum concentration of Ciprofloxacin can be increased when it is combined with Amodiaquine. The serum concentration of Ciprofloxacin can be increased when it is combined with Nicardipine. The serum concentration of Ciprofloxacin can be increased when it is combined with Fluphenazine. The serum concentration of Ciprofloxacin can be increased when it is combined with Testosterone. The serum concentration of Ciprofloxacin can be increased when it is combined with Mitotane. The serum concentration of Ciprofloxacin can be increased when it is combined with Pentazocine. The serum concentration of Ciprofloxacin can be increased when it is combined with Flurazepam. The serum concentration of Ciprofloxacin can be increased when it is combined with Daunorubicin. The serum concentration of Ciprofloxacin can be increased when it is combined with Esomeprazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Scopolamine. The serum concentration of Ciprofloxacin can be increased when it is combined with Scopolamine. The serum concentration of Ciprofloxacin can be increased when it is combined with Benzquinamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Propofol. The serum concentration of Ciprofloxacin can be increased when it is combined with Loperamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Clofazimine. The serum concentration of Ciprofloxacin can be increased when it is combined with Zonisamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Metronidazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Buprenorphine. The serum concentration of Ciprofloxacin can be increased when it is combined with Dactinomycin. The serum concentration of Ciprofloxacin can be increased when it is combined with Dipyridamole. The serum concentration of Ciprofloxacin can be increased when it is combined with Doxorubicin. The serum concentration of Ciprofloxacin can be increased when it is combined with Doxorubicin. The serum concentration of Ciprofloxacin can be increased when it is combined with Ketoconazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Fenofibrate. The serum concentration of Ciprofloxacin can be increased when it is combined with Ibuprofen. The serum concentration of Ciprofloxacin can be increased when it is combined with Nitrendipine. The serum concentration of Ciprofloxacin can be increased when it is combined with Promethazine. The serum concentration of Ciprofloxacin can be increased when it is combined with Atazanavir. The serum concentration of Ciprofloxacin can be increased when it is combined with Quinacrine. The serum concentration of Ciprofloxacin can be increased when it is combined with Sertraline. The serum concentration of Ciprofloxacin can be increased when it is combined with Miconazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Atovaquone. The serum concentration of Ciprofloxacin can be increased when it is combined with Bicalutamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Levofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Levofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Nefazodone. The serum concentration of Ciprofloxacin can be increased when it is combined with Terazosin. The serum concentration of Ciprofloxacin can be increased when it is combined with Itraconazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Estramustine. The serum concentration of Ciprofloxacin can be increased when it is combined with Mitoxantrone. The serum concentration of Ciprofloxacin can be increased when it is combined with Clarithromycin. The serum concentration of Ciprofloxacin can be increased when it is combined with Ceftriaxone. The serum concentration of Ciprofloxacin can be increased when it is combined with Chlorprothixene. The serum concentration of Ciprofloxacin can be increased when it is combined with Ergometrine. The serum concentration of Ciprofloxacin can be increased when it is combined with Lapatinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Posaconazole. The serum concentration of Ciprofloxacin can be increased when it is combined with Fosamprenavir. The serum concentration of Ciprofloxacin can be increased when it is combined with Cefoperazone. The serum concentration of Ciprofloxacin can be increased when it is combined with Mibefradil. The serum concentration of Ciprofloxacin can be increased when it is combined with Yohimbine. The serum concentration of Ciprofloxacin can be increased when it is combined with Hydroxychloroquine. The serum concentration of Ciprofloxacin can be increased when it is combined with Quercetin. The serum concentration of Ciprofloxacin can be increased when it is combined with Cholesterol. The serum concentration of Ciprofloxacin can be increased when it is combined with Zomepirac. The serum concentration of Ciprofloxacin can be increased when it is combined with Telaprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Simeprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Bosutinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Isavuconazonium. The serum concentration of Ciprofloxacin can be increased when it is combined with Cabazitaxel. The serum concentration of Ciprofloxacin can be increased when it is combined with Crizotinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Boceprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Fidaxomicin. The serum concentration of Ciprofloxacin can be increased when it is combined with Regorafenib. The serum concentration of Ciprofloxacin can be increased when it is combined with Enzalutamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Ponatinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Afatinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Ledipasvir. The serum concentration of Ciprofloxacin can be increased when it is combined with Vorapaxar. The serum concentration of Ciprofloxacin can be increased when it is combined with Suvorexant. The serum concentration of Ciprofloxacin can be increased when it is combined with Netupitant. The serum concentration of Ciprofloxacin can be increased when it is combined with Idelalisib. The serum concentration of Ciprofloxacin can be increased when it is combined with Cobicistat. The serum concentration of Ciprofloxacin can be increased when it is combined with Palbociclib. The serum concentration of Ciprofloxacin can be increased when it is combined with Daclatasvir. The serum concentration of Ciprofloxacin can be increased when it is combined with Polyethylene glycol. The serum concentration of Ciprofloxacin can be increased when it is combined with Polyethylene glycol. The serum concentration of Ciprofloxacin can be increased when it is combined with Polyethylene glycol. The serum concentration of Ciprofloxacin can be increased when it is combined with Polyethylene glycol. The serum concentration of Ciprofloxacin can be increased when it is combined with Rolapitant. The serum concentration of Ciprofloxacin can be increased when it is combined with Paritaprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Glycerin. The serum concentration of Ciprofloxacin can be increased when it is combined with Alectinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Chloroform. The serum concentration of Ciprofloxacin can be increased when it is combined with Monensin. The serum concentration of Ciprofloxacin can be increased when it is combined with Salinomycin. The serum concentration of Ciprofloxacin can be increased when it is combined with Venetoclax. The serum concentration of Ciprofloxacin can be increased when it is combined with Asunaprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Velpatasvir. The serum concentration of Ciprofloxacin can be increased when it is combined with Curcumin. The serum concentration of Ciprofloxacin can be increased when it is combined with Neratinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Dacomitinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Dacomitinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Alpelisib. The serum concentration of Ciprofloxacin can be increased when it is combined with Sarecycline. The serum concentration of Ciprofloxacin can be increased when it is combined with Letermovir. The serum concentration of Ciprofloxacin can be increased when it is combined with Piperine. The serum concentration of Ciprofloxacin can be increased when it is combined with Gallopamil. The serum concentration of Ciprofloxacin can be increased when it is combined with Lusutrombopag. The serum concentration of Ciprofloxacin can be increased when it is combined with Troleandomycin. The serum concentration of Ciprofloxacin can be increased when it is combined with Diethyl ether. The serum concentration of Ciprofloxacin can be increased when it is combined with Pibrentasvir. The serum concentration of Ciprofloxacin can be increased when it is combined with Glecaprevir. The serum concentration of Ciprofloxacin can be increased when it is combined with Testosterone cypionate. The serum concentration of Ciprofloxacin can be increased when it is combined with Testosterone enanthate. The serum concentration of Ciprofloxacin can be increased when it is combined with Testosterone undecanoate. The serum concentration of Ciprofloxacin can be increased when it is combined with Ivosidenib. The serum concentration of Ciprofloxacin can be increased when it is combined with Fedratinib. The metabolism of Amprenavir can be decreased when combined with Ciprofloxacin. The metabolism of Norethisterone can be decreased when combined with Ciprofloxacin. The metabolism of Tretinoin can be decreased when combined with Ciprofloxacin. The metabolism of Oxybutynin can be decreased when combined with Ciprofloxacin. The metabolism of Dutasteride can be decreased when combined with Ciprofloxacin. The metabolism of Finasteride can be decreased when combined with Ciprofloxacin. The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ciprofloxacin. The metabolism of Lorlatinib can be decreased when combined with Ciprofloxacin. The metabolism of Doravirine can be decreased when combined with Ciprofloxacin. The metabolism of Salmeterol can be decreased when combined with Ciprofloxacin. The metabolism of Cannabidiol can be decreased when combined with Ciprofloxacin. The metabolism of Cenobamate can be decreased when combined with Ciprofloxacin. The serum concentration of Phenobarbital can be increased when it is combined with Ciprofloxacin. The serum concentration of Trimipramine can be increased when it is combined with Ciprofloxacin. The serum concentration of Quetiapine can be increased when it is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Rifampicin. The serum concentration of Sumatriptan can be increased when it is combined with Ciprofloxacin. The serum concentration of Tetracycline can be increased when it is combined with Ciprofloxacin. The serum concentration of Irinotecan can be increased when it is combined with Ciprofloxacin. The serum concentration of Olopatadine can be increased when it is combined with Ciprofloxacin. The serum concentration of Diazepam can be increased when it is combined with Ciprofloxacin. The serum concentration of Clomifene can be increased when it is combined with Ciprofloxacin. The serum concentration of Ezetimibe can be increased when it is combined with Ciprofloxacin. The serum concentration of Ethinylestradiol can be increased when it is combined with Ciprofloxacin. The serum concentration of Hydroxyurea can be increased when it is combined with Ciprofloxacin. The serum concentration of Melphalan can be increased when it is combined with Ciprofloxacin. The serum concentration of Tegaserod can be increased when it is combined with Ciprofloxacin. The serum concentration of Naloxone can be increased when it is combined with Ciprofloxacin. The serum concentration of Nadolol can be increased when it is combined with Ciprofloxacin. The serum concentration of Vecuronium can be increased when it is combined with Ciprofloxacin. The serum concentration of Vecuronium can be increased when it is combined with Ciprofloxacin. The serum concentration of Neostigmine can be increased when it is combined with Ciprofloxacin. The serum concentration of Testosterone propionate can be increased when it is combined with Ciprofloxacin. The serum concentration of Ketazolam can be increased when it is combined with Ciprofloxacin. The serum concentration of Estriol can be increased when it is combined with Ciprofloxacin. The serum concentration of Debrisoquine can be increased when it is combined with Ciprofloxacin. The serum concentration of Belinostat can be increased when it is combined with Ciprofloxacin. The serum concentration of Trastuzumab emtansine can be increased when it is combined with Ciprofloxacin. The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ciprofloxacin. The serum concentration of Silodosin can be increased when it is combined with Ciprofloxacin. The serum concentration of Ambrisentan can be increased when it is combined with Ciprofloxacin. The serum concentration of Apixaban can be increased when it is combined with Ciprofloxacin. The serum concentration of Dabigatran etexilate can be increased when it is combined with Ciprofloxacin. The serum concentration of Fesoterodine can be increased when it is combined with Ciprofloxacin. The serum concentration of Vismodegib can be increased when it is combined with Ciprofloxacin. The serum concentration of Carfilzomib can be increased when it is combined with Ciprofloxacin. The serum concentration of Levomilnacipran can be increased when it is combined with Ciprofloxacin. The serum concentration of Dolutegravir can be increased when it is combined with Ciprofloxacin. The serum concentration of Sofosbuvir can be increased when it is combined with Ciprofloxacin. The serum concentration of Edoxaban can be increased when it is combined with Ciprofloxacin. The serum concentration of Umeclidinium can be increased when it is combined with Ciprofloxacin. The serum concentration of Nintedanib can be increased when it is combined with Ciprofloxacin. The serum concentration of Somatostatin can be increased when it is combined with Ciprofloxacin. The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Ciprofloxacin. The serum concentration of Dasabuvir can be increased when it is combined with Ciprofloxacin. The serum concentration of Ombitasvir can be increased when it is combined with Ciprofloxacin. The serum concentration of Osimertinib can be increased when it is combined with Ciprofloxacin. The serum concentration of Selexipag can be increased when it is combined with Ciprofloxacin. The serum concentration of Moxidectin can be increased when it is combined with Ciprofloxacin. The serum concentration of Elbasvir can be increased when it is combined with Ciprofloxacin. The serum concentration of Grazoprevir can be increased when it is combined with Ciprofloxacin. The serum concentration of Grazoprevir can be increased when it is combined with Ciprofloxacin. The serum concentration of Talazoparib can be increased when it is combined with Ciprofloxacin. The serum concentration of Ertugliflozin can be increased when it is combined with Ciprofloxacin. The serum concentration of Revefenacin can be increased when it is combined with Ciprofloxacin. The serum concentration of Duvelisib can be increased when it is combined with Ciprofloxacin. The serum concentration of Elagolix can be increased when it is combined with Ciprofloxacin. The serum concentration of Avatrombopag can be increased when it is combined with Ciprofloxacin. The serum concentration of Gilteritinib can be increased when it is combined with Ciprofloxacin. The serum concentration of Betrixaban can be increased when it is combined with Ciprofloxacin. The serum concentration of Bromperidol can be increased when it is combined with Ciprofloxacin. The serum concentration of Omadacycline can be increased when it is combined with Ciprofloxacin. The serum concentration of Copanlisib can be increased when it is combined with Ciprofloxacin. The serum concentration of Grapiprant can be increased when it is combined with Ciprofloxacin. The serum concentration of Fluciclovine (18F) can be increased when it is combined with Ciprofloxacin. The serum concentration of Cerliponase alfa can be increased when it is combined with Ciprofloxacin. The serum concentration of Larotrectinib can be increased when it is combined with Ciprofloxacin. The serum concentration of Levetiracetam can be increased when it is combined with Ciprofloxacin. The serum concentration of Oxcarbazepine can be increased when it is combined with Ciprofloxacin. The serum concentration of Anastrozole can be increased when it is combined with Ciprofloxacin. The serum concentration of Donepezil can be increased when it is combined with Ciprofloxacin. The serum concentration of Fexofenadine can be increased when it is combined with Ciprofloxacin. The serum concentration of Enfortumab vedotin can be increased when it is combined with Ciprofloxacin. The serum concentration of Enfortumab vedotin can be increased when it is combined with Ciprofloxacin. The serum concentration of Trastuzumab deruxtecan can be increased when it is combined with Ciprofloxacin. The serum concentration of Trastuzumab deruxtecan can be increased when it is combined with Ciprofloxacin. The serum concentration of Darolutamide can be increased when it is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be increased when it is combined with Erdafitinib. The serum concentration of Ciprofloxacin can be increased when it is combined with Lasmiditan. The serum concentration of Ubrogepant can be increased when it is combined with Ciprofloxacin. The serum concentration of Ciprofloxacin can be decreased when it is combined with Lumacaftor. The serum concentration of Ciprofloxacin can be increased when it is combined with Vemurafenib. The serum concentration of Ciprofloxacin can be decreased when it is combined with Apalutamide. The serum concentration of Ciprofloxacin can be increased when it is combined with Isavuconazole.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "915"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#print(Edata.loc[Edata['sepsis']==True])\n",
    "text = Edata['ab_interactions']\n",
    "\n",
    "print (text[20]) # print 'ab_interactions' column of 20th doc\n",
    "\n",
    "# Exactly how many documents are there?\n",
    "len(text) # the same as number of rows"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Transforming Raw Text into Features"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Transform raw text into *linguistic units*. \n",
    "\n",
    "For example, a sentence is \"a grammatical unit of one or more words that expresses an independent statement, question, request, command, exclamation, etc., and that typically has a subject 主语 as well as a predicate 谓语, as in 'Bob is here'. or 'Is Bob here?'\"\n",
    "\n",
    "We want to find the content within a text by (1) identifying the sentences, (2) getting the content from each sentence, (3) ultimately aggregate the content from each sentence to achieve full understanding of the whole text."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Steps**.\n",
    "\n",
    "1.   Sentence segmentation \n",
    "2.   Tokenization \n",
    "3.   Normalization\n",
    "        * Lowercase\n",
    "        * Stemming: remove affix \n",
    "        * Lemmatization remove infectional morphology\n",
    "4.   Stop words removal \n",
    "5.   Regular expression\n",
    "6.   Part-of-speech tagging \n",
    "7.   Named Entity Recognition\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 1. sentence segmentation\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 823 sentences in this document \n",
      "<class 'list'>\n",
      "sentence 0:  Gentamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.\n"
     ]
    }
   ],
   "source": [
    "# extract first document from the list of documents 'text' \n",
    "doc = text[1]\n",
    "# split the document into a list of sentences\n",
    "sents = nltk.sent_tokenize(doc)\n",
    "print ('There are {} sentences in this document '.format(len(sents)))\n",
    "print(type(sents))\n",
    "\n",
    "# Print sentences each on a line \n",
    "for i, s in enumerate(sents):\n",
    "    print (\"sentence %d: \" % i, s)\n",
    "    break "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2.  Tokenization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['The',\n",
       " 'risk',\n",
       " 'or',\n",
       " 'severity',\n",
       " 'of',\n",
       " 'adverse',\n",
       " 'effects',\n",
       " 'can',\n",
       " 'be',\n",
       " 'increased',\n",
       " 'when',\n",
       " 'Gentamicin',\n",
       " 'is',\n",
       " 'combined',\n",
       " 'with',\n",
       " 'Botulinum',\n",
       " 'toxin',\n",
       " 'type',\n",
       " 'A',\n",
       " '.']"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# use 10-th sentence in the document\n",
    "sent = sents[10]\n",
    "\n",
    "# Extract **tokens** of words in a sentence using a tokenizer\n",
    "tokens = nltk.word_tokenize(sent) # return a list of tokens, include 句号 period\n",
    "\n",
    "tokens"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 3. Normalization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "normaized tokens AFTER lowercase \n",
      "['the', 'risk', 'or', 'severity', 'of', 'adverse', 'effects', 'can', 'be', 'increased', 'when', 'gentamicin', 'is', 'combined', 'with', 'botulinum', 'toxin', 'type', 'a', '.']\n",
      "\n",
      "normaized tokens AFTER stemming \n",
      "['the', 'risk', 'or', 'sever', 'of', 'advers', 'effect', 'can', 'be', 'increas', 'when', 'gentamicin', 'is', 'combin', 'with', 'botulinum', 'toxin', 'type', 'a', '.']\n",
      "\n",
      "normaized tokens AFTER lemmatization\n",
      "['the', 'risk', 'or', 'severity', 'of', 'adverse', 'effect', 'can', 'be', 'increase', 'when', 'gentamicin', 'be', 'combine', 'with', 'botulinum', 'toxin', 'type', 'a', '.']\n"
     ]
    }
   ],
   "source": [
    "# lowercase by lower()\n",
    "normalized_tokens = [t.lower() for t in tokens]\n",
    "print ('\\nnormaized tokens AFTER lowercase ')\n",
    "print( normalized_tokens)\n",
    "\n",
    "# stemming by nltk.PorterStemmer().stem()\n",
    "print ('\\nnormaized tokens AFTER stemming ')\n",
    "print ([nltk.PorterStemmer().stem(t) for t in normalized_tokens])\n",
    "\n",
    "# lemmatization\n",
    "print ('\\nnormaized tokens AFTER lemmatization')\n",
    "print ([WordNetLemmatizer().lemmatize(t,pos='v') for t in normalized_tokens])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Descriptive stats"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "19668419\n"
     ]
    }
   ],
   "source": [
    "# tokenize all the docs\n",
    "tokens_of_Documents = [nltk.word_tokenize(doc) for doc in text]\n",
    "\n",
    "# combine all the tokens in all documents into a list of tokens\n",
    "tokens_all = list(itertools.chain.from_iterable(tokens_of_Documents))\n",
    "\n",
    "print (len(tokens_all)) # totally 19668419 tokens in all documents\n",
    "\n",
    "# lowercase and convert list of tokens to nltk text object\n",
    "final_tokens = nltk.Text(t.lower() for t in tokens_all)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "[('of', 1183859),\n",
       " ('the', 1183793),\n",
       " ('.', 1182580),\n",
       " ('serum', 867861),\n",
       " ('in', 857224),\n",
       " ('a', 800246),\n",
       " ('excretion', 746545),\n",
       " ('may', 736704),\n",
       " ('rate', 720140),\n",
       " ('which', 720140)]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# frequency distribution of tokens\n",
    "fdist = FreqDist(final_tokens)\n",
    "#  x-axis is the words , y-axis is the frequcny\n",
    "# show the top 30 words only\n",
    "fdist.plot(30) \n",
    "#  most 10 frequent tokens: format (token, frequency)\n",
    "fdist.most_common(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 4. Stop words removal"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Note that the most frequent words are common words in English that we call \"stop words\" \n",
    "\n",
    "e.g. may, could\n",
    "\n",
    "becasue they are not important to the analysis and in fact distort the results.\n",
    "\n",
    "let's remove them and see how they affect the order of the most frequent words distribution. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of tokens is 12558717 ; AFTER stop words removel\n"
     ]
    }
   ],
   "source": [
    "tokens_withno_stopwords = [w for w in final_tokens if w not in stop_words]           \n",
    "print (\"The number of tokens is %d ; AFTER stop words removel\" % len(tokens_withno_stopwords))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Word Concordances** 词汇一致性\n",
    "\n",
    "A word concordance captures the **context** around a word. \n",
    "\n",
    "the following example display the first 100 charcters of the first 5 matched lines that have the word \"concentration\". \n",
    "\n",
    "These paprameters can be changed as desired. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Displaying 5 of 147721 matches:\n",
      "result in a higher serum level . the serum concentration of gentamicin can be increased when it is \n",
      "vities of tenofovir disoproxil . the serum concentration of gentamicin can be decreased when it is \n",
      "result in a higher serum level . the serum concentration of gentamicin can be decreased when it is \n",
      " is combined with piperacillin . the serum concentration of gentamicin can be decreased when it is \n",
      "ne is combined with gentamicin . the serum concentration of digoxin can be increased when it is com\n"
     ]
    }
   ],
   "source": [
    "final_tokens.concordance('concentration',lines=5,width=100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5. Regular Expressions"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It allows us to search for patterns of strings in text using special arangements of special characters and numbers `(*$+a-z\\0-9!={}^)`:\n",
    "\n",
    "\n",
    "* `^` (Caret.) Matches the start of the string\n",
    "* `|` or `\"symbol\"`\n",
    "* `?` >=0 occurences of the preceding symbol, \n",
    "  - `behaviou?r` matches both behavior and behaviour\n",
    "* `*` >=0 occurences of the preceding patterns\n",
    "* `+` >=1 occurences of the preceding element \n",
    "* `\\d` matches any single digit (same as `[0-9]` )* `\\D` matches any single character that is not a digit (same as `[^0-9]` ).\n",
    "* `/w` match any letter character, \n",
    "* `/W` match any character that is not letter\n",
    "* `/s` match space\n",
    "* `/S` match any characeter but not space\n",
    "* `[  ]` match any characters in the brackets \n",
    "  - `[fc]at` matches fat, cat\n",
    "* `{n}` match n copies of the target string\n",
    "* `.` match periods \n",
    "* `()` match group of items in paranthesis, \n",
    "  - `(er)` matches player, \n",
    "  \n",
    "  - `(t|r|e){2,3}` match any string that is `2` or `3` in size and has any of the letters `t`, `r`, or `e`."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "use `re.compile(r\"regular expression\")` \n",
    "\n",
    "return matched character or string, rather than word"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['2', '400', '1']"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# matches any single digit 0-9\n",
    "p = re.compile(r'\\d+')\n",
    "p.findall('patient took 2 bills in the morning equivalent to 400mg and had 1 cup of water ')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p1 ['op', 'op', 'op']\n",
      "p2 ['o', 'o', 'op', 'o', 'o', 'op', 'o', 'o', 'op', 'o', 'o']\n",
      "p3 ['o', 'o', 'o', 'p', 'o', 'p', 'o', 'p', 'o', 'p', 'o', 'o', 'p', 'o', 'p', 'o', 'o']\n",
      "p4 ['P']\n",
      "p5 ['n', 's', 'o', 'i', 'o']\n",
      "(o|n|i|s)t\n"
     ]
    }
   ],
   "source": [
    "# match op\n",
    "p1 = re.compile(r'op+')\n",
    "\n",
    "# match o or op\n",
    "p2 = re.compile(r'op*')\n",
    "\n",
    "# match o or p\n",
    "p3 = re.compile(r'o|p')\n",
    "\n",
    "# match P\n",
    "p4 = re.compile(r'^P')\n",
    "\n",
    "# match o,n,i,s + t\n",
    "p5 = re.compile(r'(o|n|i|s)t')\n",
    "\n",
    "print ('p1', p1.findall('Patient took opioids in the past but not clear if he was prescribed opioids in this hospital, my opinion is not'))\n",
    "print ('p2', p2.findall('Patient took opioids in the past but not clear if he was prescribed opioids in this hospital, my opinion is not'))\n",
    "print ('p3', p3.findall('Patient took opioids in the past but not clear if he was prescribed opioids in this hospital, my opinion is not'))\n",
    "print ('p4', p4.findall('Patient took opioids in the past but not clear if he was prescribed opioids in this hospital, my opinion is not'))\n",
    "print ('p5', p5.findall('Patient took opioids in the past but not clear if he was prescribed opioids in this hospital, my opinion is not'))\n",
    "print (p5.pattern)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 6. POS Tagging\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('The', 'DT'),\n",
       " ('risk', 'NN'),\n",
       " ('or', 'CC'),\n",
       " ('severity', 'NN'),\n",
       " ('of', 'IN'),\n",
       " ('adverse', 'JJ'),\n",
       " ('effects', 'NNS'),\n",
       " ('can', 'MD'),\n",
       " ('be', 'VB'),\n",
       " ('increased', 'VBN'),\n",
       " ('when', 'WRB'),\n",
       " ('Gentamicin', 'NNP'),\n",
       " ('is', 'VBZ'),\n",
       " ('combined', 'VBN'),\n",
       " ('with', 'IN'),\n",
       " ('Botulinum', 'NNP'),\n",
       " ('toxin', 'NN'),\n",
       " ('type', 'NN'),\n",
       " ('A', 'NNP'),\n",
       " ('.', '.')]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sent = sents[10]\n",
    "tokens = nltk.word_tokenize(sent)\n",
    "pos_tokens = nltk.pos_tag(tokens)\n",
    "pos_tokens"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Meaning of tags**\n",
    "\n",
    "you can download the UPENN dataset which explains these tags and run the command below to learn more about their definitions.\n",
    "\n",
    "Examples of the tags are also displayed."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "VBN: verb, past participle\n",
      "    multihulled dilapidated aerosolized chaired languished panelized used\n",
      "    experimented flourished imitated reunifed factored condensed sheared\n",
      "    unsettled primed dubbed desired ...\n",
      "None\n",
      "NNP: noun, proper, singular\n",
      "    Motown Venneboerger Czestochwa Ranzer Conchita Trumplane Christos\n",
      "    Oceanside Escobar Kreisler Sawyer Cougar Yvette Ervin ODI Darryl CTCA\n",
      "    Shannon A.K.C. Meltex Liverpool ...\n",
      "None\n"
     ]
    }
   ],
   "source": [
    "# VBN: verb, past participle 过去分词\n",
    "print (nltk.help.upenn_tagset('VBN'))\n",
    "\n",
    "# NNP: noun, proper 专有名词, singular 单数\n",
    "print (nltk.help.upenn_tagset('NNP'))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 7. Named Entity Recognition (NER)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "classify named entities mentioned in text into pre-defined categories such as person names, organizations, locations, medical codes, time expressions, etc."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Note that the input to the \"ne_chunk module is the list of **POS-tagged tokens** which we stored in the `pos_tokens` variable"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(S\n",
      "  The/DT\n",
      "  risk/NN\n",
      "  or/CC\n",
      "  severity/NN\n",
      "  of/IN\n",
      "  adverse/JJ\n",
      "  effects/NNS\n",
      "  can/MD\n",
      "  be/VB\n",
      "  increased/VBN\n",
      "  when/WRB\n",
      "  (PERSON Gentamicin/NNP)\n",
      "  is/VBZ\n",
      "  combined/VBN\n",
      "  with/IN\n",
      "  (PERSON Botulinum/NNP)\n",
      "  toxin/NN\n",
      "  type/NN\n",
      "  A/NNP\n",
      "  ./.)\n"
     ]
    }
   ],
   "source": [
    "chunked_sentence = nltk.ne_chunk(pos_tokens)\n",
    "print(chunked_sentence)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Note how the ne-chunker assigned the category 'PERSON' to the medications (Gentamicin and Botulinum). \n",
    "\n",
    "`(PERSON Gentamicin/NNP)`\n",
    "\n",
    "`(PERSON Botulinum/NNP)`\n",
    "\n",
    "This is not the correct tag of course, which could happen!!\n",
    "\n",
    "Here is another example ...."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Looks better!\n",
    "Gubler was tagged as person, CDC was tagged as organization\n",
    "\n",
    " `(PERSON Gubler/NNP)`\n",
    " \n",
    " ` (ORGANIZATION CDC/NNP)`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(S\n",
      "  Dr./NNP\n",
      "  J./NNP\n",
      "  (PERSON Gubler/NNP)\n",
      "  studied/VBD\n",
      "  dengue/NN\n",
      "  at/IN\n",
      "  the/DT\n",
      "  (ORGANIZATION CDC/NNP)\n",
      "  ./.)\n"
     ]
    }
   ],
   "source": [
    "tokens = nltk.word_tokenize(u\"Dr. J. Gubler studied dengue at the CDC.\")\n",
    "\n",
    "pos_tokens = nltk.pos_tag(tokens)\n",
    "\n",
    "chunked_sentence = nltk.ne_chunk(pos_tokens)\n",
    "\n",
    "print (chunked_sentence)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## N-grams\n",
    "\n",
    "are features  that have (n) words; where n={1,2,3,...}. \n",
    "\n",
    "* 1-gram has 1 word\n",
    "* 2-gram has 2 words\n",
    "* 3-gram has 3 words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sentence The risk or severity of adverse effects can be increased when Gentamicin is combined with Botulinum toxin type A.\n",
      "[('The', 'risk', 'or', 'severity'), ('risk', 'or', 'severity', 'of'), ('or', 'severity', 'of', 'adverse'), ('severity', 'of', 'adverse', 'effects'), ('of', 'adverse', 'effects', 'can'), ('adverse', 'effects', 'can', 'be'), ('effects', 'can', 'be', 'increased'), ('can', 'be', 'increased', 'when'), ('be', 'increased', 'when', 'Gentamicin'), ('increased', 'when', 'Gentamicin', 'is'), ('when', 'Gentamicin', 'is', 'combined'), ('Gentamicin', 'is', 'combined', 'with'), ('is', 'combined', 'with', 'Botulinum'), ('combined', 'with', 'Botulinum', 'toxin'), ('with', 'Botulinum', 'toxin', 'type'), ('Botulinum', 'toxin', 'type', 'A'), ('toxin', 'type', 'A', '.')]\n",
      "\n",
      "n-grams are: ['The risk or severity', 'risk or severity of', 'or severity of adverse', 'severity of adverse effects', 'of adverse effects can', 'adverse effects can be', 'effects can be increased', 'can be increased when', 'be increased when Gentamicin', 'increased when Gentamicin is', 'when Gentamicin is combined', 'Gentamicin is combined with', 'is combined with Botulinum', 'combined with Botulinum toxin', 'with Botulinum toxin type', 'Botulinum toxin type A', 'toxin type A .']\n"
     ]
    }
   ],
   "source": [
    "# a sentence with 20 tokens 20-4+1 = 17\n",
    "print(\"sentence\", sent)\n",
    "\n",
    "# a list of 4-token tuples, totally 17 tuples\n",
    "n_grams = ngrams(nltk.word_tokenize(sent), 4)\n",
    "\n",
    "print(list(n_grams))\n",
    "n_grams = ngrams(nltk.word_tokenize(sent), 4)\n",
    "print('\\nn-grams are:', [ ' '.join(grams) for grams in n_grams])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## term-document matrix"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "- In this data, each patient is represented by a text document that describes interactions between their medications. \n",
    "\n",
    "- The text documents of the patients will be transformed into a matrix \n",
    "\n",
    "  - rows are the documents \n",
    "  \n",
    "  - columns are the word features. \n",
    "\n",
    "  - cells: **frequency of words** in a document.  "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## CountVectorizer"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**CountVectorizer** is a module in sklearn that converts a collection of text documents into a matrix of tokens counts. \n",
    "\n",
    "The parameters are:\n",
    "\n",
    "`max_features`: determines the number of features you want to use.\n",
    "\n",
    "`ngram_range`: determines whether to generate unigram (`(1, 1)`), bigram (`(1, 2)`), trigram (`(1, 3)`) features,etc.\n",
    "\n",
    "`stop_words`: if it is set to `english`, it will drop English stop words from the features set"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0      Leuprolide may decrease the excretion rate of ...\n",
       "1      Gentamicin may decrease the excretion rate of ...\n",
       "2      The risk or severity of QTc prolongation can b...\n",
       "3      Leuprolide may decrease the excretion rate of ...\n",
       "4      Leuprolide may decrease the excretion rate of ...\n",
       "                             ...                        \n",
       "910    The metabolism of Trimethoprim can be increase...\n",
       "911    The risk or severity of QTc prolongation can b...\n",
       "912    The metabolism of Clindamycin can be increased...\n",
       "913    The risk or severity of bleeding can be increa...\n",
       "914    Leuprolide may decrease the excretion rate of ...\n",
       "Name: ab_interactions, Length: 915, dtype: object"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# `text` is a pd.series that conatins all the documents. \n",
    "text = Edata['ab_interactions']\n",
    "\n",
    "text"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## define model and fit text data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# define model \n",
    "tf_vectorizer = CountVectorizer(max_features=30,\n",
    "                                ngram_range=(1, 2), \n",
    "                                stop_words='english' )\n",
    "\n",
    "# apply the vectorizer to the docs\n",
    "tf = tf_vectorizer.fit_transform(text)\n",
    "# Learn the vocabulary dictionary and return term-document matrix.\n",
    "# This is equivalent to fit followed by transform, but more efficiently implemented"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**The vectorizer output** is a n_doc * 2 matrix\n",
    "\n",
    "two columns:\n",
    "\n",
    "the first column: tuple (doc index, token index) \n",
    "\n",
    "th second column: frequency of token in that document"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<915x30 sparse matrix of type '<class 'numpy.int64'>'\n",
       "\twith 26024 stored elements in Compressed Sparse Row format>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "tf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['ampicillin', 'ceftazidime', 'ciprofloxacin', 'combined',\n",
       "       'concentration', 'decrease', 'decrease excretion', 'decreased',\n",
       "       'decreased combined', 'efficacy', 'excretion', 'excretion rate',\n",
       "       'higher', 'higher serum', 'increased', 'increased combined',\n",
       "       'level', 'levofloxacin', 'meropenem', 'piperacillin', 'rate',\n",
       "       'result', 'result higher', 'risk', 'risk severity', 'serum',\n",
       "       'serum concentration', 'serum level', 'severity', 'trimethoprim'],\n",
       "      dtype=object)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# print the features\n",
    "tf_vectorizer.get_feature_names_out()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  (0, 5)\t673\n",
      "  (0, 10)\t713\n",
      "  (0, 20)\t713\n",
      "  (0, 21)\t713\n",
      "  (0, 12)\t673\n",
      "  (0, 25)\t713\n",
      "  (0, 16)\t713\n",
      "  (0, 23)\t59\n",
      "  (0, 28)\t59\n",
      "  (0, 14)\t75\n",
      "  (0, 3)\t59\n",
      "  (0, 9)\t62\n",
      "  (0, 19)\t2\n",
      "  (0, 7)\t6\n",
      "  (0, 0)\t2\n",
      "  (0, 1)\t2\n",
      "  (0, 29)\t1\n",
      "  (0, 2)\t1\n",
      "  (0, 18)\t2\n",
      "  (0, 17)\t2\n",
      "  (0, 6)\t673\n",
      "  (0, 11)\t713\n",
      "  (0, 22)\t673\n",
      "  (0, 13)\t673\n",
      "  (0, 27)\t713\n",
      "  :\t:\n",
      "  (914, 20)\t697\n",
      "  (914, 21)\t697\n",
      "  (914, 12)\t657\n",
      "  (914, 25)\t736\n",
      "  (914, 16)\t697\n",
      "  (914, 14)\t39\n",
      "  (914, 3)\t42\n",
      "  (914, 9)\t102\n",
      "  (914, 19)\t2\n",
      "  (914, 7)\t65\n",
      "  (914, 0)\t2\n",
      "  (914, 1)\t2\n",
      "  (914, 29)\t1\n",
      "  (914, 2)\t1\n",
      "  (914, 18)\t2\n",
      "  (914, 17)\t2\n",
      "  (914, 6)\t657\n",
      "  (914, 11)\t697\n",
      "  (914, 22)\t657\n",
      "  (914, 13)\t657\n",
      "  (914, 27)\t697\n",
      "  (914, 4)\t39\n",
      "  (914, 8)\t20\n",
      "  (914, 26)\t39\n",
      "  (914, 15)\t22\n"
     ]
    }
   ],
   "source": [
    "print (tf)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "transform the sparse matrix into a dense matrix (pandas dataframe)\n",
    "\n",
    "This form of the data is used in text mining and text classification"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ampicillin</th>\n",
       "      <th>ceftazidime</th>\n",
       "      <th>ciprofloxacin</th>\n",
       "      <th>combined</th>\n",
       "      <th>concentration</th>\n",
       "      <th>decrease</th>\n",
       "      <th>decrease excretion</th>\n",
       "      <th>decreased</th>\n",
       "      <th>decreased combined</th>\n",
       "      <th>efficacy</th>\n",
       "      <th>...</th>\n",
       "      <th>rate</th>\n",
       "      <th>result</th>\n",
       "      <th>result higher</th>\n",
       "      <th>risk</th>\n",
       "      <th>risk severity</th>\n",
       "      <th>serum</th>\n",
       "      <th>serum concentration</th>\n",
       "      <th>serum level</th>\n",
       "      <th>severity</th>\n",
       "      <th>trimethoprim</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>59</td>\n",
       "      <td>0</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>62</td>\n",
       "      <td>...</td>\n",
       "      <td>713</td>\n",
       "      <td>713</td>\n",
       "      <td>673</td>\n",
       "      <td>59</td>\n",
       "      <td>59</td>\n",
       "      <td>713</td>\n",
       "      <td>0</td>\n",
       "      <td>713</td>\n",
       "      <td>59</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>269</td>\n",
       "      <td>42</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>72</td>\n",
       "      <td>49</td>\n",
       "      <td>41</td>\n",
       "      <td>...</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>211</td>\n",
       "      <td>211</td>\n",
       "      <td>553</td>\n",
       "      <td>42</td>\n",
       "      <td>511</td>\n",
       "      <td>211</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "      <td>1748</td>\n",
       "      <td>940</td>\n",
       "      <td>1312</td>\n",
       "      <td>972</td>\n",
       "      <td>488</td>\n",
       "      <td>480</td>\n",
       "      <td>364</td>\n",
       "      <td>...</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>502</td>\n",
       "      <td>502</td>\n",
       "      <td>1972</td>\n",
       "      <td>940</td>\n",
       "      <td>1032</td>\n",
       "      <td>502</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>42</td>\n",
       "      <td>39</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>65</td>\n",
       "      <td>20</td>\n",
       "      <td>102</td>\n",
       "      <td>...</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>736</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>622</td>\n",
       "      <td>502</td>\n",
       "      <td>691</td>\n",
       "      <td>543</td>\n",
       "      <td>261</td>\n",
       "      <td>219</td>\n",
       "      <td>166</td>\n",
       "      <td>...</td>\n",
       "      <td>575</td>\n",
       "      <td>575</td>\n",
       "      <td>543</td>\n",
       "      <td>36</td>\n",
       "      <td>36</td>\n",
       "      <td>1077</td>\n",
       "      <td>502</td>\n",
       "      <td>575</td>\n",
       "      <td>36</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>910</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>835</td>\n",
       "      <td>286</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>221</td>\n",
       "      <td>217</td>\n",
       "      <td>32</td>\n",
       "      <td>...</td>\n",
       "      <td>524</td>\n",
       "      <td>524</td>\n",
       "      <td>496</td>\n",
       "      <td>311</td>\n",
       "      <td>311</td>\n",
       "      <td>810</td>\n",
       "      <td>286</td>\n",
       "      <td>524</td>\n",
       "      <td>311</td>\n",
       "      <td>1411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>911</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "      <td>1748</td>\n",
       "      <td>940</td>\n",
       "      <td>1312</td>\n",
       "      <td>972</td>\n",
       "      <td>488</td>\n",
       "      <td>480</td>\n",
       "      <td>364</td>\n",
       "      <td>...</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>502</td>\n",
       "      <td>502</td>\n",
       "      <td>1972</td>\n",
       "      <td>940</td>\n",
       "      <td>1032</td>\n",
       "      <td>502</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>912</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>519</td>\n",
       "      <td>12</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>258</td>\n",
       "      <td>255</td>\n",
       "      <td>23</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>73</td>\n",
       "      <td>73</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>0</td>\n",
       "      <td>73</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>913</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>904</td>\n",
       "      <td>350</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>198</td>\n",
       "      <td>190</td>\n",
       "      <td>10</td>\n",
       "      <td>...</td>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>21</td>\n",
       "      <td>324</td>\n",
       "      <td>324</td>\n",
       "      <td>373</td>\n",
       "      <td>350</td>\n",
       "      <td>23</td>\n",
       "      <td>324</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>914</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>42</td>\n",
       "      <td>39</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>65</td>\n",
       "      <td>20</td>\n",
       "      <td>102</td>\n",
       "      <td>...</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>736</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>915 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     ampicillin  ceftazidime  ciprofloxacin  combined  concentration  \\\n",
       "0             2            2              1        59              0   \n",
       "1             2            2              1       269             42   \n",
       "2             4            4              2      1748            940   \n",
       "3             2            2              1        42             39   \n",
       "4             2            2              1       622            502   \n",
       "..          ...          ...            ...       ...            ...   \n",
       "910           2            2              1       835            286   \n",
       "911           4            4              2      1748            940   \n",
       "912           0            0              1       519             12   \n",
       "913           0            0              1       904            350   \n",
       "914           2            2              1        42             39   \n",
       "\n",
       "     decrease  decrease excretion  decreased  decreased combined  efficacy  \\\n",
       "0         673                 673          6                   0        62   \n",
       "1         511                 511         72                  49        41   \n",
       "2        1312                 972        488                 480       364   \n",
       "3         657                 657         65                  20       102   \n",
       "4         691                 543        261                 219       166   \n",
       "..        ...                 ...        ...                 ...       ...   \n",
       "910       496                 496        221                 217        32   \n",
       "911      1312                 972        488                 480       364   \n",
       "912         4                   0        258                 255        23   \n",
       "913        21                  21        198                 190        10   \n",
       "914       657                 657         65                  20       102   \n",
       "\n",
       "     ...  rate  result  result higher  risk  risk severity  serum  \\\n",
       "0    ...   713     713            673    59             59    713   \n",
       "1    ...   511     511            511   211            211    553   \n",
       "2    ...  1032    1032            972   502            502   1972   \n",
       "3    ...   697     697            657     0              0    736   \n",
       "4    ...   575     575            543    36             36   1077   \n",
       "..   ...   ...     ...            ...   ...            ...    ...   \n",
       "910  ...   524     524            496   311            311    810   \n",
       "911  ...  1032    1032            972   502            502   1972   \n",
       "912  ...     0       0              0    73             73     12   \n",
       "913  ...    23      23             21   324            324    373   \n",
       "914  ...   697     697            657     0              0    736   \n",
       "\n",
       "     serum concentration  serum level  severity  trimethoprim  \n",
       "0                      0          713        59             1  \n",
       "1                     42          511       211             1  \n",
       "2                    940         1032       502             2  \n",
       "3                     39          697         0             1  \n",
       "4                    502          575        36             1  \n",
       "..                   ...          ...       ...           ...  \n",
       "910                  286          524       311          1411  \n",
       "911                  940         1032       502             2  \n",
       "912                   12            0        73             0  \n",
       "913                  350           23       324             1  \n",
       "914                   39          697         0             1  \n",
       "\n",
       "[915 rows x 30 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "pd.DataFrame(tf.todense(),columns=tf_vectorizer.get_feature_names_out())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "- We can add trigrams to the new representation  by setting the upper bound of the `ngram_range` to `(1,3)`\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>combined</th>\n",
       "      <th>concentration</th>\n",
       "      <th>decrease</th>\n",
       "      <th>decrease excretion</th>\n",
       "      <th>decrease excretion rate</th>\n",
       "      <th>excretion</th>\n",
       "      <th>excretion rate</th>\n",
       "      <th>higher</th>\n",
       "      <th>higher serum</th>\n",
       "      <th>higher serum level</th>\n",
       "      <th>increased</th>\n",
       "      <th>level</th>\n",
       "      <th>rate</th>\n",
       "      <th>result</th>\n",
       "      <th>result higher</th>\n",
       "      <th>result higher serum</th>\n",
       "      <th>risk</th>\n",
       "      <th>serum</th>\n",
       "      <th>serum concentration</th>\n",
       "      <th>serum level</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>59</td>\n",
       "      <td>0</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>713</td>\n",
       "      <td>713</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>75</td>\n",
       "      <td>713</td>\n",
       "      <td>713</td>\n",
       "      <td>713</td>\n",
       "      <td>673</td>\n",
       "      <td>673</td>\n",
       "      <td>59</td>\n",
       "      <td>713</td>\n",
       "      <td>0</td>\n",
       "      <td>713</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>269</td>\n",
       "      <td>42</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>527</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>238</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>511</td>\n",
       "      <td>211</td>\n",
       "      <td>553</td>\n",
       "      <td>42</td>\n",
       "      <td>511</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1748</td>\n",
       "      <td>940</td>\n",
       "      <td>1312</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>1100</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>1394</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>502</td>\n",
       "      <td>1972</td>\n",
       "      <td>940</td>\n",
       "      <td>1032</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>42</td>\n",
       "      <td>39</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>699</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>0</td>\n",
       "      <td>736</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>622</td>\n",
       "      <td>502</td>\n",
       "      <td>691</td>\n",
       "      <td>543</td>\n",
       "      <td>543</td>\n",
       "      <td>619</td>\n",
       "      <td>575</td>\n",
       "      <td>543</td>\n",
       "      <td>543</td>\n",
       "      <td>543</td>\n",
       "      <td>421</td>\n",
       "      <td>575</td>\n",
       "      <td>575</td>\n",
       "      <td>575</td>\n",
       "      <td>543</td>\n",
       "      <td>543</td>\n",
       "      <td>36</td>\n",
       "      <td>1077</td>\n",
       "      <td>502</td>\n",
       "      <td>575</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>910</th>\n",
       "      <td>835</td>\n",
       "      <td>286</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>525</td>\n",
       "      <td>524</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>618</td>\n",
       "      <td>524</td>\n",
       "      <td>524</td>\n",
       "      <td>524</td>\n",
       "      <td>496</td>\n",
       "      <td>496</td>\n",
       "      <td>311</td>\n",
       "      <td>810</td>\n",
       "      <td>286</td>\n",
       "      <td>524</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>911</th>\n",
       "      <td>1748</td>\n",
       "      <td>940</td>\n",
       "      <td>1312</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>1100</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>1394</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>1032</td>\n",
       "      <td>972</td>\n",
       "      <td>972</td>\n",
       "      <td>502</td>\n",
       "      <td>1972</td>\n",
       "      <td>940</td>\n",
       "      <td>1032</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>912</th>\n",
       "      <td>519</td>\n",
       "      <td>12</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>282</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>73</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>913</th>\n",
       "      <td>904</td>\n",
       "      <td>350</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>50</td>\n",
       "      <td>23</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>715</td>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>324</td>\n",
       "      <td>373</td>\n",
       "      <td>350</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>914</th>\n",
       "      <td>42</td>\n",
       "      <td>39</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>699</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>697</td>\n",
       "      <td>657</td>\n",
       "      <td>657</td>\n",
       "      <td>0</td>\n",
       "      <td>736</td>\n",
       "      <td>39</td>\n",
       "      <td>697</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>915 rows × 20 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     combined  concentration  decrease  ...  serum  serum concentration  serum level\n",
       "0          59              0       673  ...    713                    0          713\n",
       "1         269             42       511  ...    553                   42          511\n",
       "2        1748            940      1312  ...   1972                  940         1032\n",
       "3          42             39       657  ...    736                   39          697\n",
       "4         622            502       691  ...   1077                  502          575\n",
       "..        ...            ...       ...  ...    ...                  ...          ...\n",
       "910       835            286       496  ...    810                  286          524\n",
       "911      1748            940      1312  ...   1972                  940         1032\n",
       "912       519             12         4  ...     12                   12            0\n",
       "913       904            350        21  ...    373                  350           23\n",
       "914        42             39       657  ...    736                   39          697\n",
       "\n",
       "[915 rows x 20 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "tf_vectorizer = CountVectorizer(max_features=20,\n",
    "                                ngram_range=(1,3), \n",
    "                                stop_words='english' )\n",
    "\n",
    "# apply the vectorizer to the \"text\" data\n",
    "tf = tf_vectorizer.fit_transform(text)\n",
    "\n",
    "#transform into dataframe\n",
    "pd.DataFrame(tf.todense(),columns=tf_vectorizer.get_feature_names())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "*decrease excertion* is a 2-word feature (2-gram) that appeared very frequently in the documents. "
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "name": "python"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
